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Abstract 
Background and Aims 
Computational prediction and protein structure modeling are the marvelous inventions of computer 
sciences that have come to the rescue of various biological problems. The technology has revolutionized 
the biological world of research and helped scientists and researchers to gain insights into their biological 
questions much efficiently to design experimental research. Carbonic anhydrase (CA) is ubiquitous 
enzyme existing in all living beings and most importantly serves in catalyzing the reversible reaction of 
carbon dioxide and bicarbonate interconversion.  There are at least 16 different isozymic forms of CAs in 
higher vertebrates which are mainly categorized on the basis of their sub-cellular localizations, broadly 
extracellular and intracellular. And recently, certain sub-population of transmembrane isoform CA IX, 
which is an extracellular CA, has been reported to also exist in nucleus i.e. in the intracellular environment. 
Likewise, it had been discovered that CA VI, another extracellular isoform, of non-mammalian vertebrates 
have an additional novel domain related to Pentraxins.  
The main goal of this research was to look for computational prediction of the nuclear-cytoplasmic signals 
in the sequences of all three transmembrane CAs: CA IX, CA XII and CA XIV. And, another goal was to 
model the complete structure of the complex of CA VI and Pentraxin domains of zebrafish Danio rerio. 
While additionally, some preliminary sequence analyses of the extracellular CAs and Pentraxin proteins 
were also targeted. 
 
Methods 
For the first goal, the orthologous sequences of all transmembrane CAs, CA VI and Pentraxin proteins CRP 
and SAP were retrieved from Ensembl database, and was addressed to analyses to identify some key 
features through certain bioinformatics tools. The nuclear localization signal was predicted from NucPred 
webserver tool while the nuclear export signal was predicted from NetNES webserver tool for 
  
transmembrane CAs. While for other sequence analyses, sub-cellular localization prediction was done 
from TargetP webserver, transmembrane helix prediction was done from TMHMM webserver.  
As for the second goal, the structures of both CA domain and Pentraxin domain of zebrafish was modeled 
first using homology modeling technique from their respective template structures analyzed from the PDB 
database. The homology modeling was done in MODELLER interface of Chimera visualization software. 
And subsequently, these two generated comparative models of each of the domains were docked 
together computationally using HADDOCK docking suite available in the webserver. 
 
Results 
Almost all analyzed transmembrane CA sequences were predicted to have N-terminal signal peptide, with 
few exception of some sequences that have missing N-terminal regions in their sequence reads. The 
NetNES webserver tool predicted the NES sequence motifs mostly in the starting region of the 
transmembrane helical domain of the transmembrane CAs. In addition, the NucPred webserver tool 
predicted NLS sequence motifs at the cytoplasmic domains of transmembrane CAs, right at the region 
where the transmembrane domain ends and the cytoplasmic domain starts. Most of the analyzed 
sequences of transmembrane CAs were predicted to have these nuclear-cytoplasmic signal motifs with 
just a few exceptions. Sequence analyses of transmembrane CAs revealed there were dimerization signal 
motifs in the transmembrane regions of CA XII and CA XIV that could drive the dimerization in the tertiary 
structure of the proteins. Moreover, there were two extra Cysteine residues conserved among the 
Pentraxin domain of non-mammalian CA VI which are not present in any of classical Pentraxin CRP and 
SAP. 
The comparative models of zebrafish CA VI domain was generated using human CA VI structure as the 
template and its RMSD was calculated to be 0.254 Å with reference to the template structure. Similarly, 
the comparative models of zebrafish Pentraxin domain was generated using human SAP structure as the 
template and its RMSD was calculated to be 0.288 Å with reference to the template structure. 
Successively, these comparative models of each domain were computationally docked using HADDOCK 
webserver software, and a docked complex of complete model of zebrafish CA VI with Pentraxin was 
generated having Haddock score of -115.9 +/- 5.2 and Z-score of -2.5.  
  
Conclusion 
The transmembrane CAs are predicted to have NLS and NES sequence motifs in their transmembrane and 
cytoplasmic domains distinct to these isozyme groups of CAs, which could reflect on their secondary role 
in the nucleus apart from the normal CA role in extracellular region. Similarly, computational modeling 
and/or docking study could be very useful for generating models of such biomolecular complexes whose 
structure would be otherwise difficult to determine through experimental procedures. A good quality 
model of the zebrafish CA VI with Pentraxin domain was generated through computational modeling and 
docking procedures that could be useful for researchers for concluding various interpretations.  
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1 Introduction 
Carbonic anhydrases (CAs) are the enzymes that catalyze the reversible reactions involving hydration and 
dehydration of CO2 and HCO3- respectively during active transport of CO2 across the cells to eventually 
eliminate it from the body. These enzyme catalysts consist of a metal co-factor, mostly Zinc (Zn), in its 
active site that coordinate the dissociation of a proton from a water molecule during the reversible 
reaction. Such reaction would have been much slower without the presence of the enzyme (Lindskog and 
Coleman 1973). These enzymes have been invented convergently as well as divergently during the 
evolution of life on earth to be present in all the domains of life viz. Archaea, Bacteria, and Eukarya. 
Specifically, in higher animals such as vertebrates, the alpha gene family of CAs have been dominant 
throughout their evolution and the gene family is the most studied gene family.  
Most of the studies on CAs have been based on the enzymes from higher organisms, while the prokaryotic 
CAs has a crucial role in shaping the ecology of earth’s biosphere. The prokaryotic organisms from domains 
Bacteria and Archaea have key roles in earth’s biogeochemical cycles, the CAs from these organisms help 
in procurement of CO2 required for photosynthesis, while physiology of the prokaryotes help in 
decomposing the organic matter back to atmospheric CO2 completing the global carbon cycle (Kumar and 
Ferry 2014). However, the alpha CAs present in the higher vertebrates, mostly being studied in mammals 
including humans, have their essential roles in the physiological functions in different cellular processes. 
There have been at least 16 isozyme forms of α-CAs identified so far in the vertebrates which have been 
classified further based on their sub-cellular localization (Hilvo et al. 2005; Supuran 2008).  
Among the isozymes of the α-CAs, this thesis research is mostly based on the various bioinformatics 
studies related to a group of extracellularly localized isozymes which are CA VI, CA IX, CA XII and CAXIV. 
Of these extracellular isozymes as well, the last three are categorized as transmembrane-bound CAs while 
the former CA VI is the only secreted form of all CAs. The transmembrane isozyme CA IX with its general 
function in acid-base balance, intercellular communication, and cell proliferation, has been associated 
with most cancers. A 1998 study by Saarnio et al confirmed the unusual expression of CA IX in the areas 
with a high proliferative activity of colorectal tumor cells by immunohistochemical method (Saarnio et al. 
1998). Further such studies done in various types of cancers have found out CA IX to be of great interest 
among all of the CAs in regard to their associations with cancers or tumors. Further studies that followed 
later showed that the CA9 gene expression and CA IX enzyme activity highly relates to regulating 
extracellular acidic pH and helping cancer cells in progression or metastasis, mostly under the hypoxic 
conditions of tumor cells (Ivanov et al. 2001; Robertson, Potter, and Harris 2004; Svastova et al. 2004; 
Thiry et al. 2006; Swietach, Vaughan-Jones, and Harris 2007). Another recent study found out the first 
evidence of CA IX interacting with the proteins of nuclear/cytoplasmic transport machinery in an 
interactome characterization study in hypoxic cells, a completely new finding for any alpha CAs (Buanne 
et al. 2013). This study suggested the existence of nuclear subpopulations of CA IX with its possible 
intracellular functions, distinct from their well-known role in the cell membrane.  
These novel findings related to CA IX inspired us to research further on this with various bioinformatics 
approaches available to us. Hence, we did the assessment of sequence analysis for identifying any clues 
that would give insight about these proteins to be targeted to the nucleus using various prediction 
methods, which are discussed in detail later in this thesis. One of the previous studies also showed the 
overexpression of CA12 gene in cells under hypoxic conditions contributing in tumor microenvironment 
by sustaining extracellular acidic pH, and the cancer cells to grow and spread (Ivanov et al. 2001). Similar 
 2 
 
to the analysis for CA IX, other two transmembrane CAs, CA XII and CA XIV, were also addressed to the 
sequence analysis for the predictions of nuclear/cytoplasmic transport.  
Of the membrane-bound isozymes and all the α-CAs, the only one that has been characterized to be 
existing in secreted form is CA VI, which has been identified to be present in saliva and milk secretions 
(Henkin et al. 1975; Thatcher et al. 1998; Karhumaa et al. 2001). Its physiological function has been 
associated with growth-supporting role in taste buds, while as found to be one of the elementary factors 
in mammalian milk suggests its essential role in normal growth and development of the alimentary canal 
in infants (Karhumaa et al. 2001). Some preliminary observations during the course of Maarit Patrikainen’s 
thesis in our research group discovered a different peptide sequence, found to be a Pentraxin, attached 
to the Carboxyl-terminal of the CA VI of certain species (Patrikainen 2012).  Pentraxins are distinct families 
of protein which mainly consists of short Pentraxins and long Pentraxins, usually characterized by the 
presence of a 200 residue long Pentraxin domain in their Carboxyl-terminal with an 8 amino acid 
conserved Pentraxin signature, HxCxS/TWxS, where x is any amino acid residue (Garlanda et al. 2005). 
Short Pentraxins comprises of C-reactive protein (CRP) and Serum amyloid P component (SAP), while long 
Pentraxins include PTX3, neuronal Pentraxin 1 (NP1), neuronal Pentraxin 2 (NP2), neuronal Pentraxin 
receptor (NPR) and PTX4. The main structural difference was the presence of an amino-terminal domain 
in long Pentraxins coupled to the Pentraxin domains, which is not present in CRP and SAP (Garlanda et al. 
2005). The novel type of Pentraxin domain discovered in the CA VI enzymes of non-mammalian 
vertebrates coupled to their carboxyl-terminal was found to be phylogenetically closely related to short 
Pentraxins [Tolvanen M., unpublished observation].  
To study about the Pentraxin containing CA VI, a Zebrafish CA VI protein structure model was proposed 
which is to be achieved through various bioinformatics procedures. The Protein Data Bank (PDB) has in its 
database the x-ray structure model of Human CA VI, a closest homologous protein to the Zebrafish CA VI, 
and a couple of both short and long Pentraxin proteins. This second main focus of the study was designed 
to be accomplished using Homology Modelling followed by Protein-protein Docking approaches. The 
finalized model could give better insight into the idea of how this novel CA VI domain would serve to a 
potential new role of CA VI proteins in those groups of vertebrates. 
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2 Aims of the study 
The aims of this research are to investigate more on the transmembrane CAs, to find out pieces of 
evidence about their localization into nucleus which is a new topic in any CAs so far. Various bioinformatics 
prediction methods are used to perform sequence analysis of these transmembrane CAs in multiple 
species in order to predict nuclear localization signal (NLS) and nuclear export signal (NES) in 
transmembrane CAs. Additionally few other sequence analyses are also performed for certain purposes. 
The modeling part of this research aims to model a complete structure for Zebrafish CA VI with its 
Pentraxin domain attached at the carboxyl-terminus. Each of the CA VI catalytic and the Pentraxin 
domains is to be modeled separately by Homology Modelling method, using homologous template 
structures from the PDB database. These models are then to be addressed to protein-protein docking 
method for generating a complete CA VI with Pentraxin structure, from which it may be possible to 
propose an insight how Pentraxin domain might assist the non-mammalian CA VI in associating with the 
cell membrane or with other biomolecules. 
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3 Review of literature 
3.1 Nuclear-cytoplasmic transport mechanism 
Eukaryotic cells consist of a separate nuclear compartment that is separated from the cytoplasmic 
environment with a double-layered membrane called nuclear envelope. Nucleus which houses the genetic 
material often has to transport its transcription products and other macromolecules into the ribosomes 
in cytoplasm for further processing while different proteins such as transcription factors, DNA and RNA 
polymerases, histones that are synthesized in the cytoplasm require an active transport into the nucleus. 
These mechanisms of nucleocytoplasmic transport of different macromolecules of molecular weight 
larger than ~40 kDa are carried out by family of proteins called as importins and exportins (Koepp and 
Silver 1998; Moroianu 1998; Chook and Blobel 2001; Goldfarb et al. 2004; Poon and Jans 2005; Kutay and 
Guttinger 2005). Importins are involved in actively transporting the cargo molecules from the cytoplasm 
into the nucleus, while exportins perform the transport from nucleus to the cytoplasm. These proteins 
specifically recognize signal sequences in their to-be cargo molecules following a metabolic process 
mediated by a small RAs-related Nuclear protein (Ran) or GTP-binding nuclear protein in order to 
transport the molecules actively. The proteins that need to be transported into the nucleus possess a 
nuclear localization signal (NLS), which act as a tag for importins. Likewise, those molecules requiring the 
transport from nucleus to cytoplasm possess a nuclear export signal (NES) which the exportins would 
recognize and thus bind with.  
3.1.1 Importins and exportins 
In classical nucleocytoplasmic transport pathway of macromolecules, importin-α forms a ternary complex 
with importin-β1 which then binds to NLS sequence in the cargo protein that is to be carried into the 
nucleus. These protein complexes after entering into the nucleus through nuclear pore complex (NPC), 
RanGTP binds with it which triggers the dissociation of the complex releasing the cargo protein, to ensure 
the active import of the cargo mediated by the energy dissociated from RanGTP in the form of GTP. 
Importin-α, after dissociation, is then recycled back to cytoplasm in another complex with an importin-α 
re-exporter called cellular apoptosis susceptibility gene (CAS) again in the presence of RanGTP (Koepp and 
Silver 1998; Lange et al. 2007). Alternatively, importin-β1 domain alone can also bind with some cargo 
proteins by recognizing the NLS sequence within them. The importin-β1 is recycled back to the cytoplasm 
in a complex with RanGTP (Okada et al. 2008).  
As for the nuclear export, the cargo proteins possessing NES are bound by exportin-1 (XPO1), stimulated 
by RanGTP, which are exported into the cytoplasm also through NPC. In the cytoplasm, the hydrolysis of 
RanGTP to RanGDP occurs which is catalyzed by Ran GTPase-activating protein. This promotes the 
dissociation of the complex assembly and thus the cargo protein is released. And again, the XPO1 is 
recycled back to nucleus by binding with an NPC component called Nup358 (Kutay and Guttinger 2005). 
3.1.2 NLS and NES  
A nuclear localization signal (NLS) is a stretch of an amino-acid sequence tag present in certain proteins 
that are targeted to the cell nucleus through nucleocytoplasmic transport. A typical NLS sequence consists 
of one or more stretches of positively charged basic amino acids, usually lysines or arginines, exposed on 
the protein surface that are recognized by importins. The best-characterized NLS are the classical NLS that 
are further classified as monopartite or bipartite. Monopartite are such which have one stretch of basic 
amino acids such as PKKKRKV in the SV40 Large T-antigen (first NLS to be discovered) and EEKRKR in NF-
κB p65 (Poon and Jans 2005). Bipartite signals usually have two clusters of basic amino acids, such as the 
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NLS of nucleoplasmin, KR[PAATKKAGQA]KKKK, has two basic amino acids clusters separated by a spacer 
of 10 amino acids (Dingwall et al. 1988). Both of these types of cNLSs are recognized by importin-α while 
some cNLSs are directly recognized by importin-β1 as typified by the sequence RKKRRQRRR in HIV-1 Tat 
(Truant and Cullen 1999). One of such is also importin-α which contains a bipartite NLS itself and hence is 
specifically recognized by importin-β.  
Non-classical NLSs do not have basic amino acids clusters, and they bind directly to different importin-β 
homologues (Chook and Blobel 2001). Such signals in heterogeneous nuclear ribonucleoprotein A1 and 
other proteins is directly recognized by importin-β2/transportin-1/karyopherin-β2 (Lee et al. 2006). 
Additionally, importin-independent nuclear entry systems also exist, such as viral protein R (Vpr) of HIV-1 
and β-catenin are known to directly interact with NPC components before passing through it (Jenkins et 
al. 1998; Yokoya et al. 1999). 
 Likewise, nuclear export signal (NES) is short amino acid sequence of hydrophobic residues which has an 
opposite function to that of the NLS, i.e. it targets the protein for export from the cell nucleus out into the 
cytoplasm through the NPC. The NES on the protein surface is recognized and bound by the exportins that 
transport the cargo actively. These signals recognized by exportins usually have short sequences stretch 
with several clusters of hydrophobic amino acids (often leucine), exemplified as RFLSLEPL and 
TPTDVRDVDI in cyclin D and LQKKLEELEL in mitogen-activated protein kinase (Poon and Jans 2005; Kutay 
and Guttinger 2005). The occurrence of the hydrophobic residues (L or D) with certain spacing may be 
explained by evaluating the protein structures which contain an NES, these crucial residues would usually 
orient at the same face of the adjacent secondary structures that they are associated to, enabling them 
to interact notably with the exportins (la Cour et al. 2004). RNA, which is synthesized in the nucleus, has 
to be exported into the cytoplasm but as it is composed of nucleotides and hence lacks NES, so most RNAs 
bind with protein to form ribonucleoprotein complex before getting exported to the cytoplasm. 
3.1.3 Carbonic anhydrase aspect 
The alpha gene family of carbonic anhydrases are classified into several isozymes classes mainly based on 
their sub-cellular localization, such as cytoplasmic, mitochondrial, secreted, transmembrane CAs. For 
decades of CA research, it has never been known about the functional role of any α-CAs in the cell nucleus, 
although there have been several suspicion about the same in some several experiments. It is still a 
mystery about the possible functionality of any CAs in the nucleus, however, it is also not unexpected of 
the existence of an enzyme in the nucleus with CA activity. 
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3.2 Alpha Carbonic Anhydrases 
With no any sequence or structural similarity but having similar active site confirmation and no doubt the 
function, there have been three major inventions of different families of CAs, viz. Alpha, Beta and Gamma. 
While more expansive classification also includes two additional minor families, viz. Delta and Zeta. The 
previously thought separate family of CAs, Epsilon, was later found out to be a special type included within 
Beta CA family. The β-CAs occur in most prokaryotes like bacteria, phototrophic organisms such as plants, 
and fungi (Hewett-Emmett and Tashian 1996). Likewise, the CAs from archaea and eubacteria are 
identified as γ‐CAs, later also discovered in mitochondria of plants (Alber and Ferry 1994; Parisi et al. 2004; 
Smith et al. 1999). And the δ- and ζ-classes which have cadmium as the metal co-factor in their active sites 
have been discovered in marine phytoplankton and diatoms respectively (McGinn and Morel 2008; Xu et 
al. 2008). The α-CAs predominantly occur in higher eukaryotes from arthropods to all groups of 
vertebrates, but also been reported in some prokaryotes.  
The α-CAs from mammalian species have been studied to greater extent so far than any other classes of 
CAs, there have been at least 16 different isoforms (CA I - CA Va, CA Vb - CA XV) of α-CAs identified and 
characterized in mammals (Hilvo et al. 2005; Supuran 2008). The maintenance of acid-base homeostasis 
in a living system is essential for the proper functioning of various metabolic reactions in the body. These 
metalloenzymes play a great role in regulating this balance in different cells and tissues of the body by 
catalyzing the reaction of reversible hydration of carbon dioxide and bicarbonate ions and maintaining 
the pH homeostasis. Different isoforms of the enzyme are expressed differentially in several groups of 
tissues of the body and are mainly grouped based on the specific sub-cellular localization. The broad 
groupings include mainly intracellular and extracellular forms, while more specifically in intracellular ones, 
cytosolic CAs are the group that include some of the first characterized CA isozymes CA I, II, III, VII and XIII, 
the latter two being discovered much recently than the rest which was in 70s. The other intracellular 
group includes the two mitochondrial localized isoforms CA Va and CA Vb. Likewise among the 
extracellular groups, CA VI is the only isoform to exist in secreted form in secretions such as saliva, milk. 
While, the membrane-associated forms include the isozymes CA IV, IX, XII, XIV and XV. Here, the CA IV 
and CA XV associate with the plasma membrane through a glycosyl-phosphatidyl-inositol (GPI) linkage, 
while the remaining isoforms CA IX, XII and XIV are transmembrane proteins. And lastly, the three 
remaining isoforms are often called CA-Related Proteins (CARPs) which are CARP VIII, X and XI. These 
isoforms are inactive in terms of CA catalytic activity due to the substitution of some key residues involved 
directly in the active site of the CA enzymes. 
The cytosolic CAs form the largest group consisting of five isozymes distributed in various compartments 
at the intracellular environment. The CA1, CA2, CA3 and CA13 genes are located in the same chromosome 
8 in humans while CA7 gene is in a different chromosome. And moreover, the former four genes share 
highest sequence identity with each other than with any other isoforms as well as a phylogenetic analysis 
shows a cluster of these four proteins together while CA VII lying more distantly with them than the 
mitochondrial isoforms (Barker 2013). CA II is among the most widely studied isozymes and there are 
much more crystal structures of CA II than any other CAs in the PDB repositories. The deficiency in CA II 
has often been highly linked with a syndrome called as Osteopetrosis with renal acidosis and cerebral 
calcification (Borthwick et al. 2003; Sly, Sato, and Zhu 1991). The disease is an autosomal recessive 
disorder, caused due to several different loss-of-function mutations in the CA2 gene. In a single study by 
direct sequencing method, Shah et al have identified eleven novel mutations in patients with the CA II 
deficiency syndrome and the mutations were found to be scattered over the exons of CA2 gene (Shah et 
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al. 2004), whereas there have been previously twelve different mutations identified as well in several 
studies (Venta et al. 1991; Roth et al. 1992; Hu et al. 1992; Hu, Waheed, and Sly 1995; Soda et al. 1995; 
Soda et al. 1996; Hu et al. 1997).  
Likewise, the expression of CA3 gene is highly tissue-specific, found to be differentially expressed in Type-
I muscle fibers in human skeletal muscle tissue (Shima et al. 1983) and hence often called as muscle-
specific CA. Patients with Myasthenia gravis, a neuromuscular disease, were found to have specifically an 
insufficient level of CA III in skeletal muscles (Du et al. 2009). While patients with progressive muscular 
dystrophy conditions have significantly elevated level of CA3 than the normal ones, specifically in Duchene 
muscular dystrophy (Mokuno et al. 1985; Carter et al. 1983). And similarly, autoantibodies to CA3 were 
detected to be markedly higher in Rheumatoid arthritis patients (Liu et al. 2012). Studies such as these 
are indications that CA III might be a useful marker for muscle-related diseases. In a recent de novo whole-
genome sequencing study of Amur tiger (Panthera tigris altaica) along with comparative analyses of 
genomic sequences of other Panthera-lineage felines (big-cats), various genetic signatures reflecting the 
specific molecular adaptions to big-cats’ hypercarnivorous diet and muscle strength were reported (Cho 
et al. 2013). The study identified various tiger genes evolving under positive selection which provided the 
evidences of rapid evolution of genes (MYH7, TPM4, TNNC2, MYO1A, ACTN4) that were involved in 
development of muscle contraction and actin cytoskeleton. Here, in CA III sequence comparison of tiger, 
cat, dog, giant panda, polar bear, human, mouse and opossum, six unique substitutions were found in 
tiger sequence among which two seem to be meaningful ones. The variations V217R (hydrophobic aa to 
hydrophilic aa) and D220L (hydrophilic aa to hydrophobic aa) in tiger sequence with reference to all other 
sequences (including Cat) might also have some potential significant roles in functional changes of CA III 
activity in Pantherinae sub-lineage of Felidae (excluding Cat which is from Felinae sub-lineage) which could 
have added to the distinct muscle strength evolution in big-cats.  
 
The two mitochondrial CA homologues Va and Vb show highest sequence similarity among each other, 
however, the genes encoding the proteins are located in two different chromosomes. The CA 5a gene 
maps to chromosome 16 while CA 5b gene maps to chromosome X in humans. Both of the homologues, 
CA Va and Vb, possess a leader sequence which localizes them to mitochondria of the cell (Fujikawa-
Adachi et al. 1999a). Despite their sequence similarity and same localization, CA Vb has broader tissue 
 
Figure 3-1. The portion from the MSA of CA III sequences from Tiger, Cat, Dog, Giant Panda, Polar Bear, 
Human, Mouse, Opossum showing the unique amino acid substitution in tiger sequence. The alignment was 
made with ClustalOmega. 
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distribution than CA Va which is confined mostly to the liver, skeletal muscle and kidney. And moreover, 
phylogenetic analysis estimates the two homologues of the CA V in mammals had diverged from a single 
ancestral gene around 90 million years ago (Shah et al. 2000), and since then, the mammalian CA Vb has 
been evolving much more slowly than CA Va. The differences in tissue-specific distribution, chromosomal 
location and variable evolutionary constraints among the two homologues also suggest that they have 
evolved to acquire different physiological roles. 
One group of extracellular CAs include the GPI-anchored CAs which are bound to plasma membrane 
peripherally. Glycosyl-phosphatidyl-inositol (GPI) is a glycolipid that gets attached to the C-terminus of a 
protein during post-translational modification, thus the protein originally consists of a C-terminus signal 
peptide targeting it to the Endoplasmic reticulum (ER) which is then cleaved off, and the carboxyl group 
of the new terminal amino acid residue of the protein is anchored with amino group of ethanolamine 
residue of GPI precursor, which then gets transported to the cellular membrane via Golgi apparatus as a 
lipid rafts, and reside at the exterior leaflet of the membrane (Ikezawa 2002). The CA IV and CA XV are 
bound to the cellular membrane via GPI-anchor and typically appear on the apical membrane (Zhu and 
Sly 1990; Hilvo et al. 2005). CA XV is the youngest member in mammalian α-CA family which was 
characterized and investigated during database searches by (Hilvo et al. 2005), and most probably the 
final addition to the family, as no any other CA-like homologues were found in the database search.  An 
interesting thing about this isoform is that it was detected in most of the mammalian genomes except for 
humans and chimpanzees, where it exist as a mere pseudogene that does not have any function and is 
rather never expressed. The phylogenetic analysis estimated that the CA XV is closely related to CA IV 
(Hilvo et al. 2005). In the same study, inspection of a low resolution Rhesus macaque (Macaca mulatta) 
genome also provided sufficient hints that it has also become pseudogene in the macaque, suggesting 
that the orthologues of CA15 gene in primates might have lost the function during early evolution itself 
(Hilvo et al. 2005). Additionally, further investigation on evolutionary analyses of these isozymes by a co-
author of the previous study found out another novel GPI-linked isoform, CA XVII, in vertebrates while it 
has been lost in mammals (Tolvanen et al. 2013). Another property of these three GPI-linked isozymes is 
that they consist of multiple N-linked glycosylation sites. 
CARPs are the group of inactive isozymes that does not have essential catalytic activity of CA enzymes, 
but however they have a potential alternative physiological function in the body. Each of the CARP 
isozymes (CARP VIII, X and XI) possess either one or more substitution of the three Histidine (His94, His96, 
His119) residues in its active site which co-ordinate the Zinc atom. Most of the CARP isozymes have been 
shown to have wide expression profiles in and around different tissues of the brain in humans and mice 
(Fujikawa-Adachi et al. 1999b; Taniuchi et al. 2002). The distinct expression profiles of CARPs in human 
and mouse brain have suggested its important functions in the development of the brain and nervous 
system (Taniuchi et al. 2002). These were made evident by some studies, where an Iraqi family with mild 
mental retardation, quadrupedal gait and ataxia were found to possess a defect in their CA8 gene 
(Turkmen et al. 2009). Another earlier experimental study on waddles mice showed that the CARP-VIII 
deficiency was associated with a distinctive lifelong gait disorder (Jiao et al. 2005). The sequences of each 
CARP isozymes were found to be highly conserved among each of the respective orthologues, the 
identities percentage was higher in all CARPs than in any of the other active CAs (Aspatwar, Tolvanen, and 
Parkkila 2010). The fact that the CARP sequences are very well conserved throughout many vertebrate 
taxa also suggests that their biological role have a definite significance during the evolution, despite losing 
the CA activity. 
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3.3 Transmembrane CAs 
Transmembrane proteins are integral membrane proteins that span the entirety of the biological 
membrane as oppose to the GPI-linked proteins which reside peripherally at the extracellular half of the 
lipid bilayer membrane as mentioned earlier. Transmembrane proteins can have extracellular and 
intracellular domains along linked by the membrane-spanning domain which allows the firm attachment 
of the protein to the cell membrane aided by a special class of membrane lipids called annular lipid shell. 
The structures of the transmembrane domains are basically of two types: alpha-helical and beta-barrels. 
About 1/3rd of all the proteins in humans have been estimated to be alpha-helical membrane proteins 
(Almen et al. 2009), and nevertheless, the transmembrane CAs also possess an alpha-helical and C-
terminal transmembrane domain with extracellular CA catalytic domain and intracellular cytoplasmic 
domain. Transmembrane CAs are the second largest groups of active α-CAs after cytoplasmic CAs 
comprising of three isozymes CA IX, XII and XIV. The sequence topology of these proteins consists of ~15-
37 amino acid N-terminal signal-peptide, then main CA catalytic domain of ~275-377 amino acid which 
resides outside of the cell, ~22 amino acid transmembrane domain nearby C-terminus, and finally a small 
cytoplasmic domain of ~24-32 amino acid residues (Table 3-1).  
3.3.1 Carbonic anhydrase IX 
The first transmembrane CA to be identified was CA IX, which was rather recognized initially as a novel 
tumor-associated antigen named as MN (Pastorekova et al. 1992), subsequently later whose cDNA cloning 
revealed a large CA-like domain in the sequence (Pastorek et al. 1994), and finally was characterized by 
sequence analysis in 1996 as the ninth addition to the alpha CA family, named as CA IX (Opavsky et al. 
1996). The transmembrane CA IX is a glycoprotein (Pastorekova et al. 1992), as it comprises of a distinct 
proteoglycan domain in the N-terminus which is closely related to the keratan sulfate binding domain of 
a large aggregating proteoglycan aggrecan (Doege et al. 1991), then the main CA domain, followed by a 
transmembrane helix and short intra-cytoplasmic tail (Opavsky et al. 1996). It also possesses a signal 
peptide in its N-terminus, while it is the only CA isozyme to possess such proteoglycan domain.  
The N-terminal region of the protein is found to possess similarity with helix-loop-helix (HLH) family of 
DNA binding proteins, and moreover, DNA-cellulose chromatography experiment determined the protein 
to have affinity for binding DNA (Pastorek et al. 1994). In the earlier study by the same group, it is 
mentioned that the MN protein (CA IX) has two peptides of 54 kDa and 58 kDa molecular mass and 
 
Table 3-1. Table depicting sequence topology of human CA IX protein derived from Uniprot 
(http://www.uniprot.org/uniprot/Q16790), modified by Prajwol Manandhar. 
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localized on the cell membrane in addition to the nucleus too (Pastorekova et al. 1992). Further, in the 
radioimmunoassay of MN-specific antibodies, the protein was visualized particularly in nucleoli of the 
nucleus (Zavada et al. 1993). Similarly, immunoreactivity of MN-protein in cervix carcinomas with 
glandular differentiation was found to be localized to some nuclei of neoplastic cells, the study was 
however focused on pathogenic and prognostic significance of MN-protein as cancer-biomarker (Costa, 
Ndoye, and Trelford 1995). The role of CA9 gene and its protein product as an important cancer biomarker 
has been always of a great interest to researchers since the beginning of its discovery, but the faint hints 
of its possible roles in nucleus seem to have always been overlooked. Similarly, another 
immunohistochemical study of a cancer-type under hypoxic condition has found expression of CA IX in 
perinuclear location in 46 patients and determined to associate with poor prognosis, while 3 patients 
among them also had nuclear CA IX expression (Swinson et al. 2003). Likewise, relatively with these 
findings, a nuclear protein with CA activity was determined in several rat tissues. The polypeptide of 
apparent 66 kDa mass was recognized by CA II antibodies itself and later determined by sequence analysis 
to be nonO/p54 which is an RNA and DNA binding transcription factor. The polypeptide was found to bind 
with CA inhibitor and have detectable CA activity (25 units/mg), higher than previously determined for CA 
III and CA Va. The transcriptional factor was denoted as non-classical CA, considering its CA activity might 
function in the maintenance of pH homeostasis in the nucleus (Karhumaa et al. 2000). Contemplating 
these interesting findings of DNA binding property, nuclear localization occurrences mostly under the 
influence of tumorigenesis, prognostic variable of perinuclear appearances of the CA IX and observation 
of a nuclear factor with CA activity, its plausible to speculate that CA IX could have a function in the nucleus 
and even might act as a transcription factor inducing cancer progression or cell proliferation. 
The x-ray crystallographic structure 
of the catalytic domain of human CA 
IX has been resolved with a 
resolution of 2.20 Å and R-value 
0.157 in complex with a classical 
sulfonamide CA inhibitor 
acetazolamide. The crystal structure 
unveils typical alpha-CA folds, which, 
however, differs significantly from 
other isozymes when the quaternary 
structure of the enzyme is 
considered (Alterio et al. 2009). The 
oligomerization and stability of the 
enzyme had been previously 
investigated too, where recombinant 
proteins were found in dimeric forms 
stabilized by intermolecular disulfide 
bond(s). The recombinant proteins were produced in baculovirus system in two forms of either catalytic 
domain only (CA form) or proteoglycan and catalytic domains (PG + CA form) (Hilvo et al. 2008). The PG 
domains and active site pockets of the dimeric enzyme are located on its one face, while the C-termini 
where transmembrane regions anchor the protein to cell membrane are located on the opposite face. 
The PDB structure 3IAI consists of mutation in Cys-41/Ser which is involved in an interchain disulfide bond. 
Hence, the Ser-41 residues were replaced with suitable rotamers of Cys residues in UCSF Chimera for the 
 
Figure 3-2: The dimer of CA IX structure (pdb: 3IAI), the two chains are shown in 
magenta and cyan, showing the active site Histidines (red) and Zinc (brown), disulfide 
linked Cysteines (yellow). The glucosamine (orange) sugar is shown to be attached at 
the bottom of two subunits linked with Arginines (blue). 
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depiction of disulfide linkage (Figure 3-2). The mass spectrometry experiments of the extracellular 
portions (PG + CA domains) of the CA IX recombinants in murine cell line expression system demonstrated 
unique N-linked (Asn-309) and additional O-linked (Thr-78) glycosylation sites, while the nature of 
oligosaccharides were also characterized (Hilvo et al. 2008; Alterio et al. 2009). The resolved structure 
provides an important suggestion for the CA IX specific inhibitor drug design, provided that the inhibition 
of the isozyme could aid in antitumor activity.  
3.3.2 Carbonic anhydrase XII 
Another transmembrane isozyme, CA XII, was characterized just a few years after the first transmembrane 
CA IX in two independent studies (Tureci et al. 1998; Ivanov et al. 1998). Similar to CA9, the expression of 
CA12 has also been found to be associated with tumor mainly induced by hypoxia but to a lesser extent 
(Watson et al. 2003). The human CA XII protein is a 354 amino acid polypeptide coded by the CA12 gene 
located at chromosome 15 and the protein sequence consists of 29 amino acid signal peptide, 261 amino 
acid CA catalytic domain, a short extracellular juxtamembrane segment, followed by 26 amino acid 
transmembrane helix and a 29 amino acid cytoplasmic tail. The molecular weight of the protein expressed 
in COS-7 cells was reported as 43-44 kDa and is reduced to 39 kDa upon PNGase treatment which was 
consistent with removal of two oligosaccharide chains indicating the protein has two N-linked 
glycosylation sites (Tureci et al. 1998). An overall structure of CA XII is broadly similar to that of CA IX. The 
crystal structure of CA XII is found to exist in the dimeric form which was also elucidated from its 
electrophoresis profile where the mature form of the enzyme in solution had molecular mass of 60 kDa 
suggesting its dimeric organization (Whittington et al. 2001). There is a single disulfide linkage between 
Cys-23 and Cys-203, the similar pairs are also conserved in CA IX and CA IV and it helps in stabilizing Pro-
201-Thr-202 cis-peptide linkage and anchoring the loop containing Thr-199 (Stams et al. 1996). Unlike CA 
IX, the CA XII sequence does not possess extra Cys-41 responsible for dimer stabilization in CA IX. Rather, 
the sequence analysis of CA XII earlier have revealed that its transmembrane segment consists of the 
signature motifs GxxxG and GxxxS which serve as the framework for dimerization of transmembrane 
helices in transmembrane proteins (Senes, Gerstein, and Engelman 2000; Russ and Engelman 2000). The 
crystallization study have speculated that the presence of the signature motifs in the transmembrane 
segment of CA XII mediates dimerization which persists within the membrane in the full-length protein 
(Whittington et al. 2001). This might lead into stabilizing the dimer formation in the quaternary structure 
of CA XII.  
3.3.3 Carbonic anhydrase XIV 
The final transmembrane isozyme to be discovered was CA XIV that was characterized in 1999 (Mori et al. 
1999). The study has found its broad expression in various tissues such as kidney, heart, brain, skeletal 
muscle and liver. The CA XIV is expressed in apical and basolateral membrane of hepatocytes in mouse 
liver (Parkkila et al. 2002), while its strong expression was also seen in neuronal membranes and axons in 
the human and mouse brain (Parkkila et al. 2001). The human CA14 gene located in chromosome 1 
encodes for a polypeptide of 337-amino acids whose molecular mass was found to be 37.6 kDa. The 
topology of the protein sequence is similar to other two transmembrane CAs consisting of a 15-amino 
acid signal peptide, 275-amino acid extracellular catalytic domain, 21-amino acid transmembrane helix 
and a short 26-amino acid cytoplasmic tail. The crystal structure of the extracellular domain of human CA 
XIV was reported much later and recently than the other membrane associated alpha CAs. The structure 
is resolved with a resolution of 2.00 Å and the arrangement was found to be in a monomeric form unlike 
the two previous transmembrane CAs (Alterio et al. 2014). This was supported by bioinformatics as well 
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as gel filtration analysis. Similar to CA XII, the CA XIV structure also possess Cys-23 and Cys-203 disulfide 
pair as well as no Cys-41 that serves the disulfide link between two chains in CA IX. 
3.4 Secreted CA 
Based on the sub-cellular localization, there has been only one isoform among all the alpha-CA isozymes 
in vertebrates that exist as the secreted form, the CA VI.  
3.4.1 Carbonic anhydrase VI 
The CA VI was first characterized from the ovine parotid gland while investigating bicarbonate hydration 
in the parotid gland of the sheep (Fernley, Wright, and Coghlan 1979). However, it had been already 
isolated as zinc protein from parotid saliva by gel filtration and ion-exchange chromatography and due to 
its association to taste perception, it was named Gustin (Henkin et al. 1975). Although these two studies 
went on in parallel for almost two decades until it was finally discovered in 1998 as identical protein 
(Thatcher et al. 1998). The CA VI is known to be expressed exclusively in the serous acinar and ductal cells 
of the parotid, submandibular glands following its secretion into the saliva (Parkkila et al. 1994). The 
salivary enzyme was first purified from human saliva and characterized by (Murakami and Sly 1987), each 
molecule of the enzyme had two N-linked oligosaccharide chains which were found to be of complex type. 
A specific immunoflurometric and radioimmunoassays for human salivary CA VI was developed (Parkkila 
et al. 1993), which allowed accurate quantification of CA VI in saliva and serum. The application of the 
competitive time-resolved assay later revealed that the secretion of CA VI into saliva followed a circadian 
pattern i.e. its concentration being very low while sleeping and increasing rapidly to the daytime after 
awakening (Parkkila, Parkkila, and Rajaniemi 1995). Likely, the secretion of saliva which is controlled by 
the autonomous nervous system also follows the rhythms in circadian periodicity (Helm et al. 1982; Dawes 
1972). Previous speculations on CA VI that it helps in regulating pH of saliva was disregarded, instead the 
salivary enzyme has been demonstrated to be localized in the dental pellicle, a protein film on the surface 
of enamel, on which the biofilm of bacterial plaque develops. The pellicle has the function of protecting 
teeth from continuous ions deposition from saliva and the acids produced by oral microbes. Hence, the 
CA VI located at the most favorable sites on the dental surface plays the role in catalyzing the salivary 
bicarbonate and microbe-delivered hydrogen ions to carbon dioxide and water (Leinonen et al. 1999). 
This speculation was supported by a study which found out that the lower salivary CA VI concentrations 
are associated with the prevalence of increased caries in teeth (Kivela et al. 1999). It was also suggested 
that CA VI provides protection in the esophageal and gastric epithelium from acid accumulation as 
symptoms of acid-peptic disease were observed in patients with lower concentration of CA VI in their 
saliva than the healthy subjects (Parkkila et al. 1997). Nevertheless, CA VI has been found as one of the 
elementary factors in mammary gland secretions, milk, of human and rat suggesting it is an essential 
factor in the normal growth and development of the infant alimentary tract (Karhumaa et al. 2001). 
Furthermore, the fact that Gustin/CA VI may contribute in the growth and development of taste buds or, 
in other words, taste sensation is also very intriguing (Henkin, Martin, and Agarwal 1999). Despite the 
studies for over three decades, investigations towards its exact function and physiological role still remain 
uncertain and invites huge obsession towards more research. 
The cDNA of the gene encoding CA VI in humans was cloned and characterized by (Aldred et al. 1991) and 
it was mapped to chromosome 1. The isozyme’s subunit molecular weight is 42 kDa while the molecule 
was found to have two complex type of N-linked oligosaccharide chains (Murakami and Sly 1987). Later, 
it was found to possess three potential N-linked glycosylation sites and two cysteine residues, Cys-25 and 
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Cys-207 (Aldred et al. 1991), which are also conserved in other isozymes already described earlier. There 
are small extensions of hydrophilic residues in the C-terminus of the CA VI (Jiang and Gupta 1999).  
Bioinformatics analyses of CA VI orthologues have discovered a novel domain in the CA VI of certain 
vertebrate species. An unpublished observation of CA VI sequences of some species such as frog, fish and 
chicken found out a different type of domain attached to the C-terminus of the CA VI protein. A further 
investigation on this was done later with the availability of numerous genome sequences. In the thesis 
research by Patrikainen, sequence analysis of CA VI orthologues from multiple species was performed 
where it was found out that the novel domain is present on all the species except for mammals 
(Patrikainen 2012). This novel domain was found to be related to Pentraxin proteins, and so forth it was 
concluded that the secretory CA VI in non-mammalian vertebrates is a multi-domain protein. The 
sequence analysis also confirmed the presence of signal peptide in the secretory isozyme, and very highly 
conserved N-linked glycosylation sites in the analyzed orthologue sequences. Additional experiments 
were done to produce a construct of zebrafish CA VI protein in bacterial and insect cells and to observe 
the morphology of knockdown zebrafish model (Patrikainen 2012). The sequencing of the template DNA 
verified that it codes for the correct CA VI protein, while the knockdown zebrafish embryos and fry showed 
malformations of the swim bladder and the stomach area. With the interesting findings from the research, 
aspiring studies have been undertaking in our research group since then. 
A phylogenetic study has shown that CA VI is closely related to transmembrane CAs (Hewett-Emmett and 
Tashian 1996) and a speculation have been made from an unpublished observation in our research group 
that the CA VI lost its transmembrane and cytoplasmic domain early in vertebrate evolution and attached 
Pentraxin, while subsequently losing Pentraxin later during mammalian divergence [Tolvanen, 
unpublished observation].  
3.5 Pentraxin 
In the CA VI of non-mammalian vertebrates, there is a different type of domain that is related to the 
Pentraxin (PTX) proteins. This domain is a novel type discovered in any alpha CAs. Pentraxins are a 
superfamily of evolutionarily conserved proteins that are characterized by a distinct structural motif which 
is known as the pentraxin domain, usually lying at the C-terminal region. These proteins are multimeric 
pattern recognition receptors (PRR) that are mainly made up of about five identical subunits. Based on 
the primary structure of the monomer, these proteins are mainly divided into two groups called short 
pentraxins and long pentraxins.  Short pentraxins comprise of C-reactive protein (CRP) and serum amyloid 
P component (SAP). CRP is the first PRR to be identified, and similarly SAP are classic short pentraxins 
produced in the liver in response to Interleukin (IL)-6. Long pentraxins comprise of rather numerous 
identified ones, such as PTX3, PTX4, neuronal protein (NP) 1, NP2, NPR. Basically, the primary structure of 
the short pentraxins are composed of a classic pentraxin domain of about 200 amino acid residues with a 
short N-terminal signal peptide, while the long pentraxins have starting-unrelated sequence of about 170 
amino acid residues in N-terminal region followed by the regular pentraxin domain. The Pentraxin 
domains are highly conserved across different lineages including mammals. They have also been 
characterized in invertebrates such as arthropods (Limulus polyphemus and Tachypleus tridentatus, the 
horseshoe crabs and Drosophila melanogaster, the fruitfly), and in lower vertebrates (Xenopus laevis 
African clawed frog, Danio rerio Zebrafish, Takifugu rubripes Pufferfish) (Garlanda et al. 2005).  
Sequence analysis have identified these proteins to have the Pentraxin domain of ~200 amino acid 
residues in C-terminus with an 8 amino acid long conserved signature sequence motif (HxCxS/TWxS, 
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where x is any amino acid). In a phylogenetic analysis, clusters of mainly five different groups have been 
identified. Short pentraxins are mostly clustered as a single group of the molecules. It has been observed 
that short pentraxins have diverged from others early in the evolution and that the CRP and SAP may have 
formed from duplication event just following the divergence, as both can be found in vertebrates as well 
as in arthropods (Garlanda et al. 2005). Congruently, it has been deduced previously that Human SAP as 
a close relative of CRP for the amino acid sequence homology (51%) as well as for the similar appearance 
of annular disc-like structure with pentameric symmetry in electron microscopy (Szalai et al. 1999; Pepys 
and Hirschfield 2003; Breviario et al. 1992). The different types of long pentraxins are clustered in other 
four separate groups. One group consisting of neuronal pentraxins NP1, NP2 and NPR found in mammals 
and in lower vertebrates. Another group includes PTX3, identified in mammals, birds (Gallus gallus) and 
ancient ray-finned fishes, the puffer fish and distantly related to the PTX3, Swiss cheese protein of fruitfly 
represents another single group. And, the last group consisting of recently characterized PTX4 that have 
been found in mammals as well as in zebrafish. The study speculated that groups originated independently 
through multiple fusion events between the ancestral pentraxin domain gene and other unrelated 
sequences. 
Although, their proper physiological role have not been identified, however, the availability of the 
information regarding short pentraxin CRP, SAP and long pentraxin PTX3 to have different ligand 
specificity, these proteins are suggested to provide the innate immune system with a repertoire of diverse 
receptors of distinct specificity (Garlanda et al. 2005). Different forms of CRP and SAP identified in the 
anthropod Limulus polyphemus were found to be the abundant constituents in haemolymph that are 
involved in recognizing and destroying pathogens (Shrive et al. 1999). Similarly, CRP administration in mice 
have shown to provide protection against pathogens like Streptococcus pneumonia, Haemophilus 
influenza, Salmonella enterica (Szalai, Briles, and Volanakis 1995; Weiser et al. 1998; Lysenko et al. 2000; 
Szalai et al. 2000). Likewise, SAP and PTX3 have been found to bind apoptotic cells releasing nuclear 
components, regulating their clearance and gate the activation of autoimmunity (Rovere et al. 2000). The 
neuronal pentraxins are named as such because they are involved in neuronal functions like regulation of 
neurodegeneration. NP1 was identified originally in snake venom neurotoxin as a protein binding taipoxin 
(Schlimgen et al. 1995). While, the prototype long pentraxin, PTX3, are known to be produced by dendritic 
cells and macrophages in response to Toll-like receptor engagement and inflammatory cytokines. 
Additionally, PTX3 is also considered essential in female fertility as they act as a nodal point for the 
assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. The actual functions of this 
protein superfamily still remains elusive, however the studies point out Pentraxins as multifunctional PRRs 
at the crossroads between innate, adaptive immunity, inflammation, matrix deposition and female 
fertility (Garlanda et al. 2005). 
The CA VI-related Pentraxins have not been studied about in detail in any published sources, so the 
functional role they might have along with the CA activity of the CA domain remains unknown. Some 
preliminary analysis have detected the CA VI-related Pentraxins to be related to the short pentraxins 
despite their multi-domain structure resembling the long pentraxins [Tolvanen, unpublished observation]. 
 
3.6 Homology modeling 
 In structural biology, one of the most frequently tackled problems is a functional characterization of 
protein which is usually confronted by an experimental three-dimensional (3-D) structure of the studied 
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protein. Although, the protein structures are best determined experimentally, it is not always possible 
and convenient in terms of cost, time, and purpose of the study. And moreover, there are computational 
methods to predict the structure from available experimental structures. Comparative or homology 
modeling provides the method to predict a useful 3-D model for a protein based on one or more related 
proteins of known structure. The sequence of the protein of unknown structure (target) is used to find 
the homologous proteins of known structure (template), and based on the 3-D structure of the template 
and the alignment between template and target sequences, the target protein structure is modeled. In 
homologous or closely related proteins, it has been found that the folds and overall structural orientations 
are more conserved than the sequences, however the distantly related sequences (less than 20% 
sequence identity) have very different structures (Chothia and Lesk 1986). In other words, the tertiary 
structures of homologous proteins are evolutionarily more conserved than their primary structure. It has 
also been shown that threading potentials and proper packing in the homologous protein secondary and 
tertiary structures are evolutionarily more strongly conserved than the sequence homology measured 
alone (Kaczanowski and Zielenkiewicz 2010). Hence, if sufficient similarity at sequence level is detected 
between two proteins, their structural similarity can usually be assumed. Approximately one-third of all 
protein sequences are estimated to be related to at least one protein of known structure (Rost and Sander 
1996). 
The comparative modeling methods are usually divided into several steps in different literature, but 
mainly the process consists of four different steps: template selection, target-template alignment, model 
building and model assessment. The templates are mostly identified based on the sequence alignment, 
so the first two steps are often performed together. However, alignments produced in these extensive 
database search methods are usually made through heuristic approaches that prioritize speed over 
quality. Here is a brief about steps in comparative modeling as described in (Eswar et al. 2006). 
Template search and selection 
Using the target protein sequence as the query, the experimental 3-D models of homologous proteins are 
searched in the database of known protein structures such as PDB (Deshpande et al. 2005), SCOP 
(Andreeva et al. 2004), DALI (Dietmann et al. 2001), and CATH (Pearl et al. 2005). Usually, sequence 
comparison methods like BLAST and FASTA are used for detecting similarity which usually quantifies 
results in terms of sequence identity or statistical measures such as E-value or z-score. Occasionally, 
numerous templates availability makes it possible for utilizing more sensitive searching methods like 
profile matching and Hidden Markov Models (HMM) (Gribskov, McLachlan, and Eisenberg 1987; Krogh et 
al. 1994). Whereas, to detect more distantly related homologs, other sensitive methods based on MSA 
such as PSI-BLAST are utilized. Another method evaluates the compatibility of the target sequence with 
each of the structures in the database, called protein-threading, achieved by fold recognition or 3D-1D 
alignment (Marti-Renom et al. 2000; Peng and Xu 2011). It applies sequence-structure fitness function 
such as low-resolution, knowledge-based force-fields to evaluate potential target-template matches 
which generally does not rely on sequence similarity. As a result, it often allows identification of structural 
similarity among proteins with no significant sequence similarity i.e. distantly related proteins (Dunbrack 
et al. 1997). Though, in general, the heuristic method, BLAST search, is a reliable approach that identifies 
hits with sufficiently low E-value reflecting its sufficiently close evolutionary relatedness for making a 
reliable homology model. A template with very poor E-value is generally not recommended even when 
that is the only available one, since it can lead to a generation of a misguided model. 
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Once a several potential template structures are identified by one or more of the template searching 
methods, the next task of selecting appropriate template structure for the modeling process becomes 
necessary. Usually, it’s the sequence similarity criteria that is taken into consideration while selecting a 
template, as it’s assumed that higher the sequence similarity between the target and the template 
sequences, better will be the template to be the desired one for the target. However, there are few other 
factors too that need to be taken into account before selecting a template. The first one, from the list of 
different templates, an analysis could be done simply to relate the proteins and select a template that is 
closest to the target sequence (Felsenstein 1985). While secondly, the physiological condition where the 
target supposedly exists should also be considered to look at in template’s native physiological 
background such as solvent, pH, ligands, quaternary interactions and the like. Lastly, the most important 
factor in template selection underlies in the experimental quality of the template structure. The accuracy 
of a crystallographic structure depends on the variables such as the resolution and R-factor while for a 
nuclear magnetic resonance (NMR) structure, the number of restraints per residue is the indicative factor 
for the structure’s accuracy.  
Target-template alignment 
After the target has been selected, all comparative modeling programs rely on sequence alignment to 
ascertain structural equivalences between template and target residues for constructing a homology 
model. Although such alignments are already constructed by template search methods, these procedures 
are not based on producing optimal alignment. The search methods utilize mostly heuristic approaches 
which often sacrifice quality of the alignment over speed. Hence, a specialized alignment methods need 
to be applied to construct a proper alignment after template selection. Most often, the best possible 
alignment depends on the sequence identity of template and target. If the target-template sequence 
identity is above 40%, an accurate alignment would be produced from any standard alignment methods. 
But when the target-template sequence identity is lower than 40%, the alignment generally has gaps and 
hence, careful manual interventions would often be necessary so as to minimize the occurrences of 
misaligned residues. Some alignment methods even take structural information from the template into 
account, especially this helps in avoiding gaps in secondary-structure elements, in buried regions, or 
between two residues that are far apart in space.  
Model building 
Once the starting target-template alignment is ready, the 3-D model construction can proceed through 
either of the three main methods used for this process. The initially and still most widely used method is 
called modeling by rigid-body assembly (Blundell et al. 1987; Browne et al. 1969; Greer 1981), in which 
the model is generated through few core regions, loops and sidechains obtained by dissecting the 
structures. Secondly, a method called modeling by segment matching utilizes the approximate position of 
matched atoms from the templates to determine coordinates of other atoms (Jones and Thirup 1986; 
Unger et al. 1989; Claessens et al. 1989; Levitt 1992). The third and the latest method called as modeling 
by satisfaction of spatial restraints uses a technology similar to the experimental NMR method. By 
estimating the spatial restraints from the alignment of target sequence with template structure, the 
method implies to satisfy the restraints variables using either distance geometry or optimization 
techniques (Havel and Snow 1991; Srinivasan, March, and Sudarsanam 1993; Sali and Blundell 1993; 
Brocklehurst and Perham 1993; Aszodi and Taylor 1996). Despite the different types of methods for 
generating models, their accuracies are relatively similar when considered optimally. While, the initial 
steps of template selection and alignment generation usually have a stronger impact on the model 
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accuracy especially when the models are constructed based on sequence identity of 40% and lesser. 
However, the model building method allows a degree of flexibility and automation that is important in 
generating better models. 
Model assessment 
After the model has been built, its assessment is necessary to determine the quality of the model. Usually, 
the models are first structurally compared with the experimental template structure. The most common 
method uses the root-mean-square deviation (RMSD) metric for measuring the mean distance between 
the corresponding Cα-atoms in the backbone chain of the two structures by superimposing them. It gives 
an idea about how structurally related the modeled target is to the template structure, assuming the 
structures of homologous proteins are evolutionarily better conserved. Although, this method does have 
limitations in measuring the accuracy under certain conditions such as when the core region of the model 
is correctly modeled, while some flexible loop regions in the surfaces remain inaccurate. The possibility of 
such unreliable regions can be assessed by composite score approaches which partly use atomic statistical 
potentials and energy profiles of the model. Often those information which can be extracted from the 
predicted model alone are considered more appropriate accuracy measure since it seems essential in 
estimating the accuracy of the model in the absence of the known reference structure. In situations when 
the sequence identity is poorer (< 30%), it becomes necessary to evaluate whether the template chosen 
was the correct one. For this, the environment of each residue in a model in reference to the expected 
conditions in native experimental structures are evaluated by assessing the compatibility between the 
sequence and predicted model. Several methods which applies 3-D profiles and statistical potentials (Sippl 
1990; Luthy, Bowie, and Eisenberg 1992; Melo, Sanchez, and Sali 2002) such as VERIFY3D (Luthy, Bowie, 
and Eisenberg 1992), PROSAII (Sippl 1993), HARMONY (Topham et al. 1994), ANOLEA (Melo and Feytmans 
1998) and DFIRE (Zhou and Zhou 2002) are used for this assessment. Additionally, evaluations of self-
consistency of the model are also necessary to ensure that it satisfies the spatial restraints used while 
calculating it. Several variables relating to the stereochemical properties of the model such as bond-
lengths, bond-angles, torsion angles and non-bonded contacts (Vander Waal) can be evaluated with tools 
such as PROCHECK (Laskowski et al. 1993) and WHATCHECK (Hooft et al. 1996).  
 
3.7 Data driven protein-protein docking 
To study biomolecular interaction through structural insights has become one of the main interests in 
understanding functionality of biological complexes that exist in huge bundles in the living system. 
Considering these huge mass of complexes and their often weak and flexible nature, the experimental 
methods such as X-ray crystallography and NMR spectroscopy are not always conventionally sufficient to 
get the structural insight into the complexes. The development and implementations of computational 
methods in structural biology field have improved and made possible to complement such difficulties 
posed by the classical structural methods. Moreover, the availability of a wealth of biochemical and/or 
biophysical data about the complexes have helped in implementing these information to computationally 
drive the docking of complexes in what is known as data-driven molecular docking. In simple terms, 
molecular docking can be called as the process of modeling the 3-D structure of a biological complex from 
its known subunits or other constituents. The data required to drive the molecular docking can be usually 
determined by studying the biomolecular interactions in the complexes through various biochemical and 
biophysical experimental procedures. Using the information generated through such experiments, models 
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of biomolecular complexes can be constructed from its constituents as starting raw materials. The 
constituents of the complexes should have a known structure or it could be computationally built models 
such as those produced from comparative modeling approach. In contrast, the ab-initio docking 
approaches which generally do not use any kind of experimental data are known to have difficulty in 
constructing a consistently reliable models of the complexes. Likewise, the crystallization of larger 
complexes would be the main daunting task in x-ray crystallography experiments while due to severe line 
broadening caused by large complexes in NMR experiment, it also has certain limits for solving structures 
of large complexes (van Dijk, Boelens, and Bonvin 2005). Hence, data-driven docking has proved to be a 
very convenient method of computational modeling of complex molecules. 
In general, molecular docking is the computational modeling of the quaternary structure of biological 
complexes such as those formed by interacting macromolecules. The multi-domain proteins are the most 
common candidates for such computational methods, although protein-small ligand complexes, as well 
as protein-nucleic acids complexes, also fall under the targeted attempts of molecular docking 
approaches. Docking methods predict the organization of the complexes based on the structures of its 
constituents in close possible orientation for which the predicted structures are ranked with scoring 
functions to determine the best possible naturally occurring orientations. To do this computationally, two 
things are necessary, the first is to generate all possible orientations which is called sampling and the 
second is to decide which of the generated structure would resemble its natural occurrence that is done 
by scoring all structures and ranking them accordingly. A preliminary output of a docking basically consists 
of large number of solutions, from which high ranking models are chosen for further processing that are 
considered to correspond to the real structure, while low-ranking ones are discarded (van Dijk, Boelens, 
and Bonvin 2005). During the docking itself, there are usually two ways on which the conformational 
changes of constituents are allowed for interaction. When the orientations of interacting molecules are 
allowed to vary relatively but keeping their internal geometry intact, the type of modeling is referred to 
as rigid body docking. Here, the bond angles, bond lengths and torsion angles of the interactors are not 
allowed to modify at any stage during the docking but this method would be sometimes inadequate when 
considering occurrences of substantial conformational changes within the molecules during the natural 
formation of complexes. Hence, the docking procedures have been developed to allow conformational 
changes in the internal geometry of the models of interacting molecules in what is called as flexible body 
docking. Here, the scoring of all possible conformational changes will, however, be prohibitively expensive 
in computation time, which is why the flexible docking procedures requires to intelligently select only 
small subset of possible conformational changes for scoring. Additionally, combining various kinds of 
biochemical and biophysical data with docking would relatively reduce the stress on computation time as 
well as ensure a reliable conformation of the generated models by directing of multidomain docking more 
evidently. 
The sources of data which provide information about residues in the interface regions of the complex 
macromolecules can be obtained from various biochemical and/or biophysical experiments. Different 
types of experiment provide a different level of detail and reliability in the data i.e. specificity in interface 
residue level. One of the most frequently used and reliable methods considered is mutagenesis 
experiment. The general idea of this method is that the mutation of interface residues will affect the 
interaction of the constituent molecules while mutation in non-interface residues will have no effect. The 
target residues for mutagenesis are usually selected from surface residues on the basis of conservation 
while in-depth systematic scan such as alanine scanning mutagenesis studies are also available (Clackson 
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and Wells 1995; DeLano 2002). Another source is from Mass spectrometry (MS) that are among frequently 
used tool in structural biology for studying biomolecular complexes (Hanson and Robinson 2004; 
Hernández and Robinson 2001). The popular approach used here is Hydrogen/Deuterium exchange where 
the rate of exchange is used to infer knowledge about the accessibility of the residue in question. The idea 
is that the free and unbound forms have different rates which indicates that a given residue is protected 
from the complex formation and probably must be involved in the interaction (Lanman and Prevelige 
2004; Garcia, Pantazatos, and Villarreal 2004). Another approach used in MS is by covalently linking two 
molecules by the use of cross-linking reagent following subjecting the resulting complex to peptide mass 
fingerprinting or other protein identification methods to detect residues that are close in space (Back et 
al. 2003). Despite the methods being promising, due to the difficulty in the cross-linking reaction and its 
nontrivial interpretation as well as detection of the cross-linked residues, the data from such methods 
have not often been combined with docking approaches (van Dijk, Boelens, and Bonvin 2005). Different 
from the conventional use of NMR methods in structure determination, it can also be used to map 
interface regions of biomolecular complexes with a method called as chemical shift perturbation (CSP) 
experiments (Zuiderweg 2002). There are other NMR techniques that are able to provide similar 
information about interface regions such as Hydrogen/Deuterium exchange, cross-saturation and residual 
dipolar couplings, pseudocontact shift (Takahashi et al. 2000; Bax 2003).  
There are several other experimental techniques for identifying information about the interface regions. 
The data produced through whichever mechanisms should be reliable for use in the computational 
docking approaches. As discussed earlier, there are generally two stages in this computational method, 
the generation of all possible conformations of the complexes or sampling and the scoring of the 
generated models. Under various criteria, different type of sampling methods can be used. A rigid body 
docking are performed when using a grid representation of molecules by calculating correlations of 
surface complementarity with fast Fourier transform methods (Gabb, Jackson, and Sternberg 1997; 
Mandell et al. 2001). Likewise, when explicit representation by atomic models of proteins are used, 
sampling methods such as Monte Carlo (Knegtel, Boelens, and Kaptein 1994), molecular dynamics 
methods (Dominguez, Boelens, and Bonvin 2003) or genetic algorithms (Morris et al. 1998) in combination 
with simulated annealing schemes can be used. While scoring is typically done using force fields 
(Mackerell 2004) of atom-atom or residue-residue pair’s energy assignment, following the calculation of 
overall energy for a given configuration. Force fields can be derived based on physical factors or can be 
based on statistical information from database i.e. by identifying how often a given pair occurs in 
experimental structure database. The data-driven docking approach has advantage over ab-initio docking 
which basically have to deal with unnecessary sampling and/or scoring of tens to hundreds of false 
positives. The data-driven docking can relax strains on both these stages by producing more relevant 
conformations during sampling while improving the ranking of true positives in the scoring stage. The 
main difference between various methods that utilizes this approach exist in this scenario that whether 
the experimental data are incorporated in sampling stage or only during scoring stage in order to filter 
the generated samples. Although this docking approach has considerable advantages, every method has 
disadvantages too, and computational docking in itself is an unsolved problem. The field of docking in 
structural bioinformatics is still in active development, and no any docking method produces the perfect 
solution, rather they are just the close-possible ones. 
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3.8 Tools and theory 
3.8.1 Ensembl 
Ensembl is a genome browser (www.ensembl.org) that features the sequenced genomic information of 
mostly vertebrates with a particular focus on key model organisms such as humans, mouse and zebrafish 
(Flicek et al. 2013). It is a project jointly undertaken by European Bioinformatics Institute and Wellcome 
Trust Sanger Institute in 1999 with the Human Genome Project around the corner to be completed. The 
genome annotations are mostly done through an automated gene annotation system that predicts the 
gene locations which is made available for access through a MySQL database for further analysis as well 
as viewing. The database houses genomic, transcriptomic and proteomic sequence data that can be 
accessed through different tools available in the browser and also programmatic interfaces. There are 
new releases of the database every 3 months which involve changes mostly the inclusion of new species 
sequences. The database is equipped with a Perl API (Application Programming Interface) through which 
the data could be accessed programmatically, that is further divided into sections. Such as for comparative 
genomic study, the compara API is used for predicting different homolog relationships. As for the 
sequence retrieval of orthologs, a recent implementation of a Representational State Transfer (REST) API 
was utilized as an updated version to the ‘Orthologer’ script (described in Section 4.1) (Yates et al. 2015; 
Barker 2013). The Ensembl REST enables the easy retrieval of different data from the database with the 
use of various other programming languages other than Perl.  
3.8.2 Python 
Python is a high-level programming language which is an open-source free software (www.python.org). 
Its codes are highly readable and the syntax requires comparatively fewer lines of code than with other 
languages such as C, C++ or Java. Unlike the curly braces used by most other languages, it uses whitespace 
indentation for delimiting blocks. A start of certain statement body is followed by an increase in 
indentation while a decrease in the indentation signifies its end. All programmatic scripting done in this 
thesis for different tasks were written in Python language. Python v2.7 was used despite the existence of 
newer version Python v3, basically for the full compatibility of a bioinformatics-based supplementary 
subroutine called biopython.  
3.8.3 Biopython 
Biopython is a collaborative project of an international team of developers, which is an open-source 
collection of various Python tools designed to perform tasks related to computational molecular biology 
or bioinformatics. It is a collection of Python modules which consists of classes that can be used 
programmatically for various bioinformatics analysis tasks. Basically, it is a platform designed for 
bioinformaticians to easily access the tools and perform various analysis through python scripts (Cock et 
al. 2009). Sequence file formats like fasta and alignment file formats can be easily parsed through scripts 
for reading and writing and to perform various analyses.  There are modules that are designed to deal 
with 3D protein model structures, and other bioinformatics tools such as BLAST, ClustalW and EMBOSS 
can also be accessed. Online databases of biological information such as NCBI can also be accessed 
through a programmatic interface with the help of biopython modules. Different sequence analyses done 
in this thesis have frequently utilized biopython based scripts. 
3.8.4 Clustal Omega 
It is a stand-alone program designed to perform multiple sequence alignment (MSA) of protein and 
nucleotide sequences in much faster and reliable way. Homologous sequences often need to be aligned 
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to infer any relationships and information required for sequence analysis and also inferring phylogeny. 
Most methods compute the alignments of larger datasets while compensating the accuracy, whereas 
others produce better quality alignments but at the expense of ease of computation as the number of 
sequences increase. The algorithm of Clustal Omega have been developed to produce quality alignments 
while also allowing infinite sample sizes with great computation power (Sievers et al. 2011). In the Clustal 
Omega, a modified version of mBed (Blackshields et al. 2010) with a complexity of O(N log N) is 
implemented that produces accurate guide trees. All sequences are embedded in a space of n dimensions 
(n ~ log N) and then replaced by an n element vector where each element is the distance to one of n 
reference sequences. Then these vectors can be clustered extremely quickly by standard methods such 
as UPGMA or K-means. Finally, the alignments are computed by HHalign package (Soding 2005), it aligns 
two profile hidden Markov models (Eddy 1998) which produce very accurate alignments. Additional 
feature includes allowing users to specify an HMM profile from an aligned MSA of homologous sequences 
of the input set. All the sequence alignment tasks performed during various analyses during this thesis 
research was performed with the Clustal Omega, available in webserver 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) at European Bioinformatics Institute (EBI).  
3.8.5 Prediction webservers 
3.8.5.1 NetNES 1.1 Server 
This webserver tool is a program developed to perform throughput analysis of protein sequences for 
predicting Nuclear Export Signals (NES). The NetNES program employs two different machine learning 
algorithms, a significant improvement over the generally used consensus patterns, for predicting NESs (la 
Cour et al. 2004). In eukaryotic cells, nuclear compartments are separate from the cytoplasm, which is 
why it becomes essential for the active nucleo-cytoplasmic transport of macromolecules across these 
compartments. This program predicts the leucine-rich NESs in eukaryotic proteins and for it, the program 
combines hidden Markov models (HMM) and artificial neural network (ANN) methods. These models are 
trained with datasets contained in NESbase 1.0 (la Cour et al. 2003) which consists of 64 proteins having 
67 high-confidence NESs. Each residue in a submitted sequence is assigned an HMM score and an ANN 
score calculated through the trained models, and another algorithm post-processes the scores to assign 
a final score to every sequence position. The output of the program displays all three HMM, ANN and 
post-processed ‘NES’ scores. This allows for manual inspection of individual scores for possible 
misprediction due to either of the models failing to recognize or falsely recognizing the NES motif. The 
NetNES predictor is made available at (http://www.cbs.dtu.dk/services/NetNES) webserver. 
3.8.5.2 NucPred 
This is also a webserver tool designed for analyzing patterns in eukaryotic protein sequences and 
predicting nuclear localization signals (NLS). The NLS are a stretch of positively charged basic amino acid 
sequences in those proteins that are destined to the nucleus. This novel tool NucPred for predicting NLS 
is based on a different machine learning algorithm called genetic programming (GP) that induces regular 
expression matching and multiple program classifiers (Brameier, Krings, and MacCallum 2007). The GP is 
such type of machine learning method that spontaneously develops computer programs in an artificial 
evolutionary process (Koza 1992). The predictors incorporate multiple regular expressions that are 
evolved together with actual classification rules for matching against the input sequence. In this way, the 
predictor uses the evolutionary information from the sequence profiles and these evolved sequence 
motifs are not restricted to a predefined set of NLS patterns, so this program has potential to discover 
even novel and unknown NLSs. For user-submitted multiple sequences, the webserver has two different 
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ways where a likelihood score is calculated in either input of a 15 related sequence sets at one time 
producing alignment, or up to 1000 sequences in batch mode. In the multiple sequences, the scores are 
calculated for each residue and are colored in a spectrum of red to blue based on the influence of the 
residue on nuclear classification. The closer the subsequence color lies at the red end of the spectrum, 
the more positive is its effect for nuclear location, while vice-versa when it lies towards the blue end of 
the spectrum. The web interface to the NucPred tool is made available at 
(https://www.sbc.su.se/~maccallr/nucpred/) webserver. 
3.8.5.3 TMHMM Server v.2.0 
This is a program developed for predicting transmembrane helices in integral membrane proteins. The 
program TMHMM is also housed in a webserver and its algorithm is based on hidden Markov model 
(HMM). This software is devised to detect full topology of the protein sequences with the total number 
of transmembrane helices and their in/out orientation with respect to the cell membrane. This program 
incorporates various criteria of transmembrane helices potentiality into a specialized model that consists 
of submodels designed to model specific regions of a membrane protein through several HMM states. 
Different criterion for prediction of transmembrane helices like hydrophobicity signal, charge bias signal, 
helix lengths and grammatical constraints are employed in the HMM which provides high degree of 
accuracy, reliability and better prediction (Krogh et al. 2001). An evaluation of several methods found 
TMHMM to be the best-performing transmembrane prediction program (Moller, Croning, and Apweiler 
2001). 
3.8.6 RCSB Protein Data Bank (PDB) 
The PDB is a repository of experimental 3-D structures of macromolecules such as proteins, nucleic acids 
and macromolecular complexes. The database is the single archive worldwide for structural data of the 
biological molecules, mostly protein structures (about 90% of the total data), determined through 
experimental methods such as X-ray crystallography, NMR, cryoelectron microscopy and theoretical 
modeling (Berman et al. 2000). It was first established at Brookhaven National Laboratories (BNL) in 1971, 
which is currently overseen by a central organization called Worldwide Protein Data Bank (wwPDB).  The 
parent organization consists of host members viz. PDB in Europe (PDBe, http://www.ebi.ac.uk/pdbe/), 
PDB Japan (PDBj, http://pdbj.org/) and Research Collaboratory for Structural Bioinformatics (RCSB, 
http://www.rcsb.org). RCSB has the sole responsibility of the management of PDB since 1998, and it is the 
most popular and major host of wwPDB that is mostly accessed (Berman et al. 2000). As the member, 
RCSB curates and annotates data that are deposited by diverse groups of researchers such as biologists, 
biochemists, computer scientists from around the world. The data are made publicly accessible on the 
Internet via three different websites of its member organizations (PDBe, PDBj, and RCSB). The structural 
data of the macromolecules are universally written in pdb file format. The file compiles the parameters 
obtained from the experimental methods in a textual script format that consists of description and 
annotation of the macromolecule (protein, nucleic acid) structures such as its atomic coordinates, 
observed sidechain rotamer(s), secondary structure assignments and atomic connectivity. The structures 
are often deposited along with other molecules used in the experiment settings such as water, ions, 
ligands, inhibitor molecule which are also described in the pdb format file. This file format can be accessed 
for structural simulation or analysis through different molecular visualization software such as UCSF 
Chimera. 
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3.8.7 UCSF Chimera with MODELLER interface 
UCSF Chimera is a molecular visualization software package developed by the Resources for 
Biocomputing, Visualization and Informatics (RBVI) at the University of California, San Francisco. Chimera 
can be used for various purposes of visualizations and analyses of protein 3-D model structures, nucleotide 
structures. Various types of structural editing can be performed using Chimera for producing very high-
resolution images of publication quality that are essential in this thesis research. The structural analyses 
such as hydrogen bond, contact and clash detection; distance, angles, surface area, volume 
measurements; structure building and bond rotation; morphing between different conformations of 
proteins etc. are some of the basic capabilities of the software package. Along with these, Chimera is also 
implemented with further extensible visualization tools. In general, the package is segmented into a core 
which provides basic services and visualization facilities as mentioned above, and extensions for even 
higher level functionality. Such architecture satisfies the demands of third-party developers who wish to 
incorporate new features in their products (Pettersen et al. 2004). One example of such extension is 
MultiAlign Viewer (Meng et al. 2006) for analyzing multiple sequence alignment and associated structures 
that is applicable in various purposes such as structure comparison based on sequence conservation and 
also for comparative modeling. 
Another extension tool in the Chimera that is an important part of this research is MODELLER interface. 
The MODELLER is a platform for doing comparative modeling of protein three-dimensional structures 
(Eswar et al. 2006; Marti-Renom et al. 2000). The homology models are produced based on the user-
submitted initial alignment of the target and template sequences along with a script defining the required 
parameters for the modeling. The incorporation of this suite in Chimera provides more comprehensive 
graphical user interface (GUI) for setting up of input data and parameters in simplified way required for 
the modeling process, evaluating results and also performing various types of refinement during model 
generation. The BLAST web-service for searching potential templates from the PDB database is itself 
integrated into the tool as well as the alignment of the target and selected template will be made through 
ClustalW algorithm in the MultiAlign Viewer. And finally based on the target and template sequence 
alignment with the known structure of the template, the MODELLER suite can be called either locally or 
via web-service. The MODELLER runs in the background and generates models within few minutes which 
are directly displayed in the Chimera interface along with their associated scores. The whole interface is 
very user-friendly that greatly facilitate modeling tasks as well as maximizes the coverage, resolution, 
accuracy and efficiency for the structural characterization of macromolecular assemblies. 
3.8.8 HADDOCK webserver 
HADDOCK is an information-driven flexible docking platform which incorporates prior experimental 
information or predicted protein interface data in ambiguous interaction restraints (AIRs) for performing 
the docking between proteins, nucleic acids and any other biomolecules. The HADDOCK docking suite 
differentiates from other ab-initio docking programs in the fact that it utilizes information from identified 
or predicted protein interfaces to drive the docking process (de Vries, van Dijk, and Bonvin 2010). The 
data-driven approach implemented in the docking suite can support a wide range of experimental data, 
such as from mutagenesis, mass spectrometry or various NMR techniques (chemical shift perturbation 
(CSP), residual dipolar couplings (RDCs) or hydrogen/deuterium exchange). The determined information 
are entered in the form of active and passive residues that are interpreted as AIRs by the program and 
used for directing the docking by automatically generating the topology of the molecules to be docked. 
This docking is driven in a similar manner as AIRs based on classical NMR distance restraints data which 
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drive the structural calculation of an NMR structure (Linge et al. 2003). The docking protocol follows 
mainly three stages, firstly a rigid-body energy minimization, secondly semi-flexible refinement in torsion 
angle space and finally, a refinement in explicit solvent. The structures are scored and ranked after each 
of the stages and accordingly kept for the next stage. The HADDOCK program allows for full structural 
flexibility of both side chains and backbone of the biomolecules. Few other docking programs built prior 
to the HADDOCK can only allow the structural flexibility but only at the side chain level, as well as only 
some could deal with nucleic acids. The HADDOCK server is powered up by a dedicated cluster because of 
which a docking run typically takes a few hundreds of CPU hours. While additionally, the server can also 
make use of GRID computing resources deployed across Europe within FP7 e-NMR e-Infrastructure 
European project (http://www.enmr.eu) when the main HADDOCK server is too busy or down for 
maintenance/upgrading. The HADDOCK webserver is available at (http://haddock.chem.uu.nl/haddock) 
and the GRID enabled version at (http://haddock.chem.uu.nl/enmr). Both requires registration through a 
web form for access. 
The HADDOCK webserver can also incorporate bioinformatics predictions interface data when the 
experimental information is sparse or absent. A tool called as CPORT (Consensus Prediction of Interface 
Residues in Transient complexes) is implemented in the web-server for predicting interface residues of 
the protein structures (de Vries and Bonvin 2011). The CPORT is developed to integrate the interface 
predictions suitable for use in the HADDOCK program by combining six interface prediction webservers 
into a consensus method. The CPORT predictor generates a list of active and passive residues that can 
directly be entered into the HADDOCK webserver as input parameters. However, the interface residues 
are usually over predicted by CPORT, which could be further improved by interface post-prediction, by 
using any other information regarding the probable docking solutions. The CPORT is very helpful when no 
experimental information are available and thus also presents an alternative to ab initio docking methods. 
The CPORT takes in PDB file of the structure and along with the lists of the interface residues, it also 
generates a PDB file containing the information regarding the prediction. The active and passive 
predictions are incorporated in the B-factor (temperature) column of the PDB file, which can be easily 
visualized in various molecular graphics software for e.g. UCSF Chimera through rendering by B-factor 
attribute. 
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4 Research methodologies 
4.1 Sequence retrieval 
All the protein sequences required for various bioinformatics analyses were retrieved from Ensembl 
database using a pipeline, written in python language, called ‘Orthologer’ developed in our research group 
by Harlan Barker (Barker 2013). The python script employs over twenty python modules including 
biopython, fetches data from the Ensembl database through REST API, while calling multiple external 
bioinformatics programs and retrieves and processes data before finally producing usable sequence 
datasets. It has to be operated through Unix/Linux systems for full accessibility because some external 
programs are unavailable in Windows system. After the sequence retrieval from the database, each 
orthologues are processed for ‘good’ or ‘bad’ quality analysis on the basis that it is a ‘bad’ sequence if it 
does not have starting-Methionine, an ‘X’ in the sequence, or if its length deviates more than 5% from the 
corresponding human orthologous sequence. And optionally for the sequences assigned as ‘bad’, 
predictions can be made with Exonerate (Slater and Birney 2005) program, called within the pipeline, for 
extracting a better quality protein sequence from the genome than that annotated in the public database. 
The Ensembl Ids of the required proteins are given as input to the Orthologer to retrieve their orthologous 
sequences from the database. Here, the Ids of human genes for each CA isozymes: CA IX, CA XII, CA XIV 
and CA VI are used to retrieve the orthologous protein sequence datasets of the respective isoforms. And 
similarly for the Pentraxins, the human gene Ids of Pentraxin proteins CRP and SAP were used to retrieve 
their corresponding orthologous sequences. The Ensembl Gene Ids for each protein that were used as 
input are shown in the Table 4-1. 
S.N. Protein Ensembl Gene Ids 
1.  CA IX ENSG00000107159 
2.  CA XII ENSG00000074410 
3.  CA XIV ENSG00000118298 
4.  CA VI ENSG00000131686 
5.  CRP ENSG00000132693 
6.  SAP ENSG00000132703 
Table 4-1. The Protein names and their Ensembl Gene Ids 
After the retrieval, the ‘bad quality’ assigned sequences were manually inspected in Multiple Sequence 
Alignment made with ClustalOmega. Since, the quality analysis algorithm of Orthologer will also skip out 
any sequences which just do not have initial ‘M’ despite rest of the features being very fit for further 
analyses, the bad quality sequences of transmembrane CAs were manually inspected and selected for 
analysis based on conditions that the sequence did not have any ‘X’ character, and the transmembrane 
and/or cytoplasmic portions were intact. 
 
4.2 Sequence analyses 
In preliminary analyses, predictions of sub-cellular localization and transmembrane helices for 
orthologues of transmembrane CAs: CA IX, CA XII and CA XIV were performed. The following programs 
were used in the World Wide Web (www) for the predictions. TargetP 1.1 Server for secretory signal 
peptides, mitochondrial targeting peptides or other location (cytoplasmic) in non-plant organism groups 
of eukaryotes using the cutoffs of 95% specificity was implemented for sub-cellular location prediction. 
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The potential cleavage site of the predicted presequence was also predicted in the TargetP analysis for 
which SignalP is used. Likewise, TMHMM Server v.2.0 is used to predict transmembrane helices and along 
with it, the analysis generates some statistics and locations of the predicted transmembrane helices and 
the topologies for the intervening loop regions whether it lies outside or inside of the membrane.  
The subsequent major sequence analyses in the research include the prediction of nucleo-cytoplasmic 
transport signals in the orthologous protein sequences of transmembrane CAs: CA IX, CA XII and CA XIV. 
For predicting Nuclear export signals (NES) in the protein sequences, the analysis was performed in the 
program NetNES 1.1 Server available at (http://www.cbs.dtu.dk/services/NetNES) that uses ANN and 
HMM algorithms. As stated by (Buanne et al. 2013), the regions encompassing only TM and IC portions of 
the human CA IX sequence were used mainly for the simplicity during their NES prediction analysis. But 
the technical explanation to the statement is that the algorithms of the program would have to analyze 
considerably larger set of parameters when the longer amino acid segments are fed and that would 
require correspondingly large training datasets which are not available in the current development of the 
program (la Cour et al. 2004). So when the full sequences were used, it produced a lot of irrelevant noises 
with detections of false-positive faint signals along with misprediction of the actual NES signal. Hence, all 
the sequences were trimmed to contain only last 60 amino acids segment i.e. sixty residues starting from 
the C-terminal end of the sequences that would include the TM and IC portions, and it was achieved 
programmatically through a Python script utilizing biopython module for parsing sequence objects. These 
truncated sequence datasets were submitted to the NetNES webserver for prediction of the NES signals. 
As for the prediction of Nuclear localization signal (NLS) in the protein sequences, the program called 
NucPred was used in its server available at (https://www.sbc.su.se/~maccallr/nucpred/) which uses 
genetic programming algorithm. For the multiple sequence submission, the program has limits up to 15 
sequences at a time. So as required, the orthologous sequence datasets were divided into batches of 
subsets containing 15 or fewer sequences, which was performed programmatically through a Python 
language script utilizing biopython module for parsing sequence objects. The subsets of sequence were 
then submitted to the NucPred Server under Protein family service that takes up to 15 related sequences 
and generates an MSA made from ClustalW which is colored according to the scores predicted by 
NucPred. 
Other minor analyses performed are explained as follows. The orthologous sequences of CA XII and CA 
XIV were analyzed for dimerization motifs in the transmembrane regions of the proteins. The CA XII and 
CA XIV sequences were aligned separately in ClustalOmega and the MSA were visually inspected for the 
presence and conservation of the dimerization sequence motifs in the transmembrane helices portions of 
the sequences. And lastly, the orthologous sequences of non-mammalian CA VI which consists of 
Pentraxin domain were aligned with the orthologous sequences of CRP and SAP in ClustalOmega to 
analyze sequence variation and conservation especially for certain conserved regions of the Pentraxin 
proteins such as Cys residues that has functionality in formation of disulfide bridges within the sub-unit. 
 
4.3 Homology modeling of Zebrafish CA VI and Pentraxin domain 
The homology modeling of two different domains: CA VI catalytic domain (hereafter called CA VI domain) 
and Pentraxin domain of the Zebrafish were each performed separately using MODELLER interface tool in 
UCSF Chimera. However, the procedures for the modeling involves pretty much the same principle except 
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for some additional analyses performed as needed in case of the CA VI catalytic domain which is described 
in detail below. The methodologies for each domain are described in separate sections. 
4.3.1 Homology modeling of CA VI domain 
The PDB database was searched for homologous proteins of zebrafish CA VI domain with known structures 
using the zebrafish CA VI sequence as a query. This was performed using the Chimera. The query sequence 
was loaded in the Chimera, which opens in MultiAlign Viewer tool. The query sequence can be BLASTed 
against PDB database from menu Info -> Blast Protein using all the default Blast parameters such as E-
value threshold of 1e-3 and Blosum62 matrix. The 3-D structure of human CA VI with PDB Id: 3FE4 was 
found to be the best hit with lowest E-value (lower the better) of 5e-79.  
Template evaluation and refinement 
The 3FE4 is the only structure of any CA VI isozyme and it has been resolved with resolution of a 1.9 Å 
(Pilka et al. 2012). A structural evaluation of the crystal structure was done. The crystallography study 
included a fragment from 21-290 amino acids (GeneBank entry 21706434) of the catalytic domain and 
TEV-cleavable His6-tag was incorporated at the C-terminal end for purification (Pilka et al. 2012). Later, 
the cleavage has left extra seven residues in the end (AENLYFQ) (Figure 4-1), which are not any part of CA 
VI sequence. Also, in the final construct, the structural data is not available at all for the last 18 residues. 
A preliminary analysis on this missing C-terminal sequence fragment had predicted it to resemble an 
amphipathic (AP) helix (Figure 5-4). Before the structure could be used as the template, a refinement 
process of the structure to include the helical region was performed. The presumed amphipathic helix 
was modeled from I-TASSER (Iterative Threading ASSEmbly Refinement) Server (Zhang 2008) and it was 
docked to the C-terminal face of the PDB structure 3FE4 (described detail in Section 4.4) in HADDOCK 
 
Figure 4-1. Secondary structure of the human CA VI (PDB Id: 3FE4, Pilka et al, 2012). Residues without structural data are 
non-underlined, the last seven residues in grey box is non-CA VI sequence left by His-tag added during purification. 
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Server and the final model saved in PDB format file. The refined structure of CA VI (3FE4) with the 
amphipathic helical region was used as the template for modeling the zebrafish CA VI domain.  
Template-target alignment 
The second task in the modeling is to make a pair-wise alignment of the target and template sequence. 
The alignment was produced with ClustalOmega for a better-quality alignment, as a good alignment 
serves as main drive into generating a good model, and it was brought into an optimal alignment (Figure 
4-2). The N-terminal signal peptide fragments of both target and template sequence were trimmed from 
the alignment as it was not part of the template structure. Similarly, the last 5 residues (RRALN) from 
human CA VI sequence was removed as there was no structural data (Figure 4-2) and the Pentraxin 
domain region was also trimmed from zebrafish CA VI sequence. Finally, the sequence alignment is used 
to determine the orientation of corresponding residues in the target by exploiting the information from 
the template structure. 
Model generation 
The alignment is loaded in Chimera which opens in MultiAlign Viewer (MAV). The interface to the 
MODELLER can be started either locally or via web-service from MAV menu option: Structure -> Modeller 
(homology). The MODELLER relies on the principle of constructing models by the satisfaction of spatial 
restraints. The information such as spacing between atoms, bond lengths, bond angles, dihedral angles, 
etc. are extracted from the template structure in the form of spatial restraints and then the target 
structure is constructed by satisfying all these restraints in best possible way. The MODELLER takes about 
3-4 minutes on the Modeller web-service to construct the homology model and generates five (default) 
comparative models with their associated quality scores, GA341 (Melo, Sanchez, and Sali 2002) and zDOPE 
(Shen and Sali 2006). GA341 score is derived from statistical potentials, and a value greater than 0.7 
indicates a reliable model with more than 95% chances of having the correct fold. Similarly, zDOPE or 
normalized Discrete Optimized Protein Energy is a statistical score derived from the atomic distance, and 
negative values indicate better models. In addition to this, the quality of models can also be assessed by 
structural comparison to the template structure, by using the MatchMaker tool in Chimera (Tools -> 
Structure comparison -> Matchmaker), Cα RMSDs scores were calculated for each of the comparative 
models. And lastly, unfavorable clashes or contacts such as close contacts between atoms or direct 
interactions of polar and nonpolar residues was calculated for each of the comparative models by using 
Find Clashes/Contacts tool in Chimera (Tools -> Structure Analysis -> Find Clashes/Contacts). Agreement 
 
Figure 4-2. An optimal alignment between target and template sequences is constructed with ClustalOmega. For the 
residues in red box, no structure data is available. 
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on the best model was made on the basis of the majority in best scores from these four different quality 
analyses. 
4.3.2 Homology modeling of Pentraxin domain 
In a similar way, the sequence part of the Pentraxin domain of zebrafish CA VI was used as a query for 
searching potential template structures in PDB database. As the chimera enables a comfortable access to 
the BLAST portal service, the target Pentraxin sequence was loaded in Chimera that opens up in MAV tool. 
From the MAV tool, the query sequence was subjected to BLAST (Info -> Blast Protein) with default setting 
of E-value threshold 1e-3 and Blosum62 matrix, that returned numerous homologous structures of short 
Pentraxin proteins from Homo sapiens and Limulus polyphemus available in the PDB database. Based on 
the highest resolution of 1.4 Å, the crystal structure of hSAP protein of PDB Id: 4AVS was chosen as the 
best template for homology modeling. 
Target-template alignment 
For producing a good quality pair-wise alignment, the target and template sequences were aligned using 
ClustalOmega. The CA VI domain from the zebrafish sequence was trimmed and the N-terminal signal 
peptide from the hSAP sequence and its corresponding aligned amino acids in Pentraxin (zebrafish-CA VI) 
sequence were also trimmed for further structural analysis. The optimal alignment with sequence identity 
of 30.2% was finally produced, that could be used in the further procedure of driving model generation. 
 
Model generation 
The target-template sequence alignment was loaded in Chimera that opens up in MAV tool. The interface 
to the Modeller in Chimera was started by choosing Structure -> Modeller (homology) from the MAV menu 
option. Then by choosing the target and the template, the Modeller was run via web-service. Again, the 
Modeller builds the comparative models based on satisfaction of the spatial restraints as explained 
before. With 3-4 minutes of computation time on its server clusters, the Modeller returned five different 
homology models along with their statistical measures of model accuracy, GA341 (Melo, Sanchez, and Sali 
2002) and zDOPE (Shen and Sali 2006). An additional structural comparison scores are calculated which 
are displayed in the Reply log dialog box of the Chimera, the Cα RMSDs scores for each of the models are 
calculated with reference to the template structure by superimposing the target models with the template 
structure. As a final analysis, a clash/contacts were calculated from Find clash/contacts option that can be 
chosen from Tools -> Structural analysis -> Find clashes/contacts in the Chimera menu option. The 
 
Figure 4-3. An optimal alignment between template (hSAP) and target (zPtx-CAVI) is made with ClustalOmega. The residues 
in white box of zebrafish sequence are trimmed out, since there is no corresponding residues in the human sequence. 
 
 30 
 
agreement on choosing the best final model was made based on the models having the majority of best 
scores from these four different structural analysis.  
4.3.3 Model assessment 
For statistical potentials or physics-based calculation assessment of the modeled structures, PROCHECK 
was used. The PDB files of the models were uploaded to the PROCHECK webserver, and the statistical 
report of the analysis was generated by the software package, which produces various physiochemical 
statistical data of the models. For structural comparison, the modeled target structures are structurally 
superimposed with each of the corresponding template structures to measure the root mean square 
deviation (RMSD) between corresponding atoms in the two structures. Energy minimization was 
performed in Chimera with Structure minimization tool. The final resulting models were used for further 
docking experiments. 
 
4.4 The docking of CA VI and Pentraxin domains 
The model of full-length zebrafish CA VI + Pentraxin complex was built by docking them using the 
HADDOCK web-server (http://haddock.science.uu.nl) with its Easy interface since it is the most 
convenient one as of the scope of this research. The program utilizes user-defined input parameters of 
active and passive residues to drive the docking process. Active residues are those residues in the interface 
of each subunit of the complex that are directly involved in the interaction, whereas passive residues 
correspond to their solvent-accessible surrounding surface residues. The input data was also predicted 
 
Figure 4-4. The Easy interface of the Haddock web porta for submitting models of two models for docking. 
(http://haddock.science.uu.nl/services/HADDOCK/haddockserver-easy.html).  
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through computational approach using CPORT program available in the Haddock web-server. CPORT 
implements a protocol to predict interface residues that can be used as input data into the Haddock’s 
data-driven docking suite. This tool is extremely helpful in our docking step as no any experimental 
information about the interface residues are available and this thesis research was fully based on 
bioinformatics approaches. The CPORT combines six different interface prediction web servers into a 
consensus method and generates a list of predicted interface residues. The PDB files of each 
protein/amphipathic helix produced during previous modeling step were submitted to the CPORT server 
(http://haddock.science.uu.nl/services/CPORT) with threshold option ‘Very sensitive’ that is 
recommended for HADDOCK. The server returns output as lists of active and passive residues which can 
be directly included in the HADDOCK docking procedure. The CPORT also incorporate these information 
into B-factor column of the PDB file, which can be visualized in Chimera by rendering the B-factor 
occupancies in the surface coloring that in actual is active and passive residues parameters. HADDOCK 
interprets these information of active and passive residues in the form of Ambiguous Interaction 
Restraints (AIRs) to drive the docking process. 
The CPORT predicted information were noted down for each of the molecules, and later used during 
docking. There were two different runs of docking required in this thesis. Firstly, a docking was done 
between the 3FE4 structure and the predicted Amphipathic helix structure of the human CA VI in order 
to generate its complete structural model which can be used further as template in the homology 
modeling of zebrafish CA VI domain. It was obvious in a near-approximate way that the AP-helix would fit 
on the C-terminal face of the 3FE4 structure. So the only those predicted residues lying on the C-terminal 
face of the 3FE4 structure were given as input, and similarly the residues in a hydrophobic part of the AP-
helix was given as input in the HADDOCK web portal. 
And secondly, a docking was performed between the models of zebrafish CA VI domain and Pentraxin 
domain that were produced from the comparative modeling in the previous step (Section 4.3). Here, it 
was obvious that the C-terminal face of the CA VI domain would interact with the N-terminal face of the 
Pentraxin domain. Hence, only those predicted residues lying at the particular aforementioned surfaces 
of each domain were provided as input to the HADDOCK submission portal.  
Using this information in the form of AIRs, the HADDOCK performs the docking in the clusters of its servers 
and usually it takes about approximately 5 hours of computation time to complete the docking, depending 
on the queue pending jobs in their server. Finally, an ensemble or clusters of models are produced with 
their quality scores. From the cluster having the best score, a top model of the docked protein complex is 
chosen for further analysis or interpretation. 
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5 Results 
5.1 Retrieval of sequences from Ensembl 
The orthologous sequences of CAs IX, XII, XIV, VI and short Pentraxins CRP and SAP were pulled from the 
Ensembl database with Orthologer Python-script.  
Species CA IX CA XII CA XIV CA VI CRP SAP 
Homo sapiens X X X X X X 
Gorilla gorilla  X X X X X 
Pan troglodytes X X X  X X 
Pongo abelii X X  X  X 
Nomascus leucogenys X X X X X X 
Macaca mulatta X X X X X X 
Microcebus murinus  X   X X 
Callithrix jacchus X X X  X X 
Tarsius syrichta     X X 
Otolemur garnettii X X X  X X 
Felis catus X X X X  X 
Procavia capensis X  X  X X 
Equus caballus X X    X 
Loxodonta africana X X X   X 
Echinops telfairi X     X 
Bos taurus X X X  X X 
Vicugna pacos   X   X 
Ailuropoda melanoleuca X X X   X 
Canis familiaris X X X    
Sus scrofa X    X X 
Ochotona princeps X  X  X X 
Oryctolagus cuniculus X X X  X X 
Mus musculus X X X  X X 
Rattus norvegicus X X X   X 
Ictidomys tridecemlineatus X X X  X X 
Monodelphis domestica X X X  X X 
Tursiops truncatus  X     
Mustela putorius furo  X X   X 
Pteropus vampyrus X X X   X 
Myotis lucifugus X X X X   
Sorex araneus X      
Erinaceus europaeus    X   
Sarcophilus harrisii X X    X 
Cavia porcellus X X X  X X 
Dipodomys ordii X  X   X 
Sarcophilus harrisii   X    
Dasypus novemcinctus   X    
Macropus eugenii   X    
Danio rerio X   P   
Meleagris gallopavo X X  P   
Gallus gallus X X  P   
Xenopus tropicalis  X X P   
Latimeria chalumnae X X X P   
Tetraodon nigroviridis  X     
Xiphophorus maculatus   X P   
Oryzias latipes   X P   
Oreochromis niloticus   X    
Pelodiscus sinensis  X  P   
Anas platyrhynchos  X     
Gadus morhua    P   
Ficedula albicollis X X  P   
Takifugu rubripes  X  P   
Taeniopygia guttata    P   
TOTAL SPECIES 33 35 33 20 18 30 
Table 5-1. The table showing orthologous sequences of different species retrieved from Ensembl for each of the proteins. Bold X 
represents the ones that were originally bad-quality sequence, P represents those CA VI consisting of Pentraxin domain. 
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The good and usable bad quality sequences were collected for other bioinformatics analyses. In total, 
there were 33, 35, 33, 20, 18 and 30 sequences for CA IX, CA XII, CA XIV, CA VI, CRP and SAP respectively. 
The Table 5-1 lists the species names from which the orthologous sequences of each of the proteins were 
retrieved for further analyses in this thesis. 
 
5.2 Sub-cellular localization and Transmembrane helices prediction 
TargetP predictions 
The transmembrane CA sequences were submitted to TargetP server for prediction of sub-cellular 
localization signal. Among the 33 CA IX sequences, three sequences were not predicted to have any 
signaling pre-sequence while rest 30 sequences were predicted to have N-terminal secretory signal 
peptide. The length of the predicted signal peptide was 37 in the majority of sequences whereas it ranged 
from 31 to 50. Similarly, for 35 analyzed CA XII sequences, only 22 sequences were predicted to have N-
terminal secretory signal peptide, while the rest were not predicted to have any signal sequence. And 
lastly, for 33 CA XIV sequences, 28 were predicted to have N-terminal secretory signal peptide, 4 were not 
predicted of any signals, and interestingly one sequence was predicted to be targeted to Mitochondria. 
The results output are given in Appendix I. 
TMHMM predictions 
All the orthologues of CA IX, CA XII and CA XIV were predicted to possess transmembrane helix which is 
an obvious observation for transmembrane proteins. The majority of the transmembrane helices were 
predicted to be composed of 22 amino acids, with an exception of 18 amino acids in Canis familiaris CA IX 
sequence. The CA IX of Ictidomys tridecemlineatus and CA XIV of Latimeria chalumnae sequences had 
predictions of two transmembrane helices, but the extra ones were found to be N-terminal signal peptides 
mispredicted as transmembrane helices when visually inspected in MSA. The results output are given in 
Appendix II. 
 
5.3 NES and NLS motifs in transmembrane CAs 
NetNES Prediction 
The transmembrane CAs orthologues sequences were subjected for the Nuclear export signal in the 
NetNES Server. The sequences were truncated to contain last 60 amino acids from the C-terminal end for 
submitting to the NetNES server. There were positive predictions in most of the transmembrane CAs 
sequences. Among CA IX, 32 out of 33 sequences showed NES predictions where most of them had very 
strong signals. Similarly for CA XII, 28 out of 35 sequences showed the NES predictions. Likewise, 8 
sequences of CA XIV did not show positive predictions, while remaining 25 sequences showed strong to 
moderate signals. The server calculates a consensus NES score from HMM and ANN scores, all the three 
scores are shown in the output result. Some mispredictions could be the result of either of two algorithms 
failing to recognize the NES motif site completely or partially. From the MSA, there was very high degree 
of conservation observed in the region of predicted NES motif sites (Figure 6-1, Figure 6-2, Figure 6-3). 
The results output are given in Appendices III and IX. 
NucPred 
The transmembrane CAs were also subjected to NLS site prediction in a different server called NucPred, 
where almost every sequences were predicted to contain NLS subsequence motif. The server creates a 
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colorful MSA of submitted set of sequences based on a scale of whether the subsequence regions are 
predicted to have nuclear signals or not. The scale goes from blue which is negative (non-nuclear) signal 
towards red which is positive (nuclear) signal. In CA IX sequences, signals were moderately detected 
towards the C-terminal region. A single cluster of basic amino acids Arg and Lys are observed to be highly 
conserved among all species. These clusters appear to occur into the end region of predicted location of 
the transmembrane domain and starting of the cytoplasmic domain. In contrast, the CA XII sequences 
have very brightly colored region of the positive nuclear signals being detected. In most of the sequences, 
the detection are observed to the extent that the clusters of the highly conserved basic amino acids are 
even underlined in the MSA. Lys is mostly conserved in all the species while there are moderate levels of 
conservation of Arg too. Similarly also in CA XIV sequences, there are even very highly detected signals for 
nuclear localization with almost all the detected sequence motifs as underlined in the MSA output. Both 
Arg and Lys seem to be equivalently conserved among most species and the detected sequence motif is 
also at the similar location as of CA IX and CA XII i.e. starting position of cytoplasmic domain (Figure 6-1, 
Figure 6-2, Figure 6-3). The result output are given in Appendices IV and IX. 
 
5.4 Dimerization signal in transmembrane helix 
It is previously reported that in the transmembrane region of human CA XII, there are GxxxG and GxxxS 
sequence motifs that signal for transmembrane helix dimerization (Whittington et al. 2001; Senes, 
Gerstein, and Engelman 2000; Russ and Engelman 2000). The sequence motifs for dimerization were 
analyzed in all orthologous sequences of CA XII in the MSA. It was observed there is a high degree of 
conservation of the sequence motifs in most of the orthologous sequences, especially in the good quality 
sequences. These signal motifs of those CA XII sequences having 100% conservation are highlighted in the 
MSA (Figure 5-1).  
 
Figure 5-1. The part from MSA of CA XII orthologous sequences having 100% conservation in the transmembrane 
dimerization motifs (GxxxG and GxxxS).  
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Additionally, the CA IX and CA XIV sequences were also visually analyzed for the presence of the 
dimerization signal motifs. It was not observed in CA IX sequences, but the CA XIV of most of the species 
were found to have a very good conservation of the motifs, but in lesser extent to that found in CA XII 
sequences. The MSA from those CA XIV sequences is shown in Figure 5-2 having fully conserved 
dimerization signal motifs. 
 
Figure 5-2. The part from MSA of CA XIV orthologous sequences having 100% conservation of the transmembrane dimerization motifs (GxxxG and GxxxS). 
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5.5 Sequence analysis of Pentraxin domain 
The sequences of Pentraxins proteins: CRP, SAP and CA VI Pentraxin domain were aligned with 
ClustalOmega. Only five representative sequences from each of the proteins were included during 
alignment. The sequence features such as Pentraxin signature motif HxCxS/TWxS and conserved Cys 
residues involved in disulfide bridge formation were visually inspected in the alignment. There was high 
degree of conservation of the signature motif in almost all sequences. The two Cys residues known to 
form disulfide linkage in CRP and SAP structure are also found to be conserved in the CA VI Pentraxin 
domain of the five species. While additionally, there were two other Cys residues fully conserved among 
the CA VI Pentraxin sequences and was not present in other short Pentraxin proteins. The two novel Cys 
residues conserved in the CA VI Pentraxins could have a role in disulfide bond formations. The alignment 
with annotation is shown in Figure 5-3. 
 
 
 
 
 
 
 
 
Figure 5-3. The Multiple sequence alignment of some of representatives of each CAVI Pentraxin domain, CRP and SAP; made with ClustalOmega. The horizontal lines drawn 
to connect ‘C’s depicts disulfide bridges formed between two Cys residues. The Cys columns are highlighted with yellow, the HxCxS/TWxS motif is highlighted in grey. 
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5.6 The CA VI has amphipathic helix at C-terminus 
To model a zebrafish CA VI domain, the only closest homologous structure available in PDB was the 
structure of human CA VI (3FE4). The crystal structure of the human CA VI has 29 amino acids missing 
from its C-terminal end. Of the missing sequence fragment, 18 residues were predicted to have an 
amphipathic helical property as shown in (Figure 5-4, A) by HelicalWheel Projection 
(http://rzlab.ucr.edu/scripts/wheel/wheel.cgi). The putative amphipathic helix region was modeled by I-
TASSER program as an alpha helical structure and the secondary structure prediction of the residues in C-
terminal end was also shown to be helical with very high confidence scores of 8 or 9. The overall C-score 
of the model was calculated as -1.49 in a scale of [-5, 2], where higher value signifies a model with high 
confidence. The visualization of the helix structure in Chimera clearly exhibited the predicted amphipathic 
conformation as shown in (Figure 5-4, B). In correspondence to this, a structural inspection of 3FE4 pdb 
structure in Chimera highlighted hydrophobic patches in the C-terminal face of the protein 3-D structure 
(Figure 5-5, A), where the hypothetical helical structure would fit. The CPORT analysis also predicted 
interface residues which coincide well with the hydrophobic patches (Figure 5-5, B). The restraint 
parameters i.e. active and passive residues for docking were selected from overlapping residues of the 
hydrophobic patches and the CPORT prediction in the C-terminal face of the CA VI (3FE4) structure (Figure 
5-5, C). The selected parameters for active residues are A117, A234, V134, and I121; and for passive 
residues are V57, I131, V168, and F236 in 3FE4 pdb file.  
The docking of the AP-helix and 3FE4 structures were done in HADDOCK server. The docking was 
completed in about 3 hours of computation time in the server, and returned seven different clusters of 
models. The top model from cluster 1 having best Haddock score of -109.3 +/- 4.5 was chosen for further 
analysis (the one with lowest Haddock score is the best). The hydrophobic contacts calculated between 
the predicted interface residues in 3FE4 and AP-helix was found to be 45 hydrophobic or pseudo bonds 
(Appendix VII). The visualization of the model in Chimera shows that the helix fits seemingly perfectly in 
the hydrophobic patches supporting our hypothesis. The full and refined 3-D model of human CA VI 
structure was usable as a template for modeling the zebrafish CA VI domain. 
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Figure 5-4. [A] The helical wheel diagram of sequence fragment (underlined) from C-terminus of human CA VI, red colored 
amino acids in the sequence are residues with no structural data available in 3FE4 pdb file; [B] The structure of Amphipathic 
helix modeled by I-tasser and visualized in Chimera, the amino acids lying in the non-polar face of the helix are labelled, the 
residues are colored based on hydrophobicity from highest-red, mid-white to lowest-blue. 
 
 
 
Figure 5-5. The visualization of human CA VI structure (PDB id 3FE4), the surface facing towards the reader is the C-terminus face, based on 
following criterias: [A] The surface is colored according to hydropathy (red to blue represents hydrophobic to hydrophilic); [B] Here the surface 
is colored based on interacting residues predicted by CPORT (red represents active residues, white passive residues, and blue as non-
interacting); [C] The surface is primarily colored based on hydropathy in similar way as in A, but the interacting residues from B that overlaps 
with the hydrophobic patches in A are highlighted here differently (yellow represents active residues and green passive residues), and the 
predicted interacting residues are labelled too. 
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Figure 5-6. The hydrophobic contacts was calculated with default contact cutoffs of -0.4A with an allowance of 0.0A. The 
visualization showing the pseudobonds are shown in different angles: [A] The side view with reference to the AP-helix; [B] The 
direct front view showing the AP-helix in front; [C] The 180’ rotation vertically of A; [D] The 90’ rotation horizontally of B or 
top view with reference to the main axis of AP-helix. The residues involved in hydrophobic contacts are displayed and the 
pseudobonds between them are shown as yellow connecting lines. 
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5.7 The modeled 3-D structure of zebrafish CA VI with Pentraxin domain 
The refined human CA VI structure consisting of AP-helix was used as the template for modeling the 
zebrafish CA VI domain using GUI to Modeller in Chimera. The Modeller generated five comparative 
models with individual statistical scores GA341 and zDOPE. Additionally, the RMSDs was measured for 
each of the models through structural comparison with template structure and intramolecular Clashes 
were calculated in Chimera. The analysis scores are shown in Table 5-2. Based on the majority of winning 
scores, the best comparative model #1.4 was chosen for further analyses. The model was subsequently 
subjected to energy minimization in Chimera with Structure minimization tool. The energy minimization 
was performed with 100 steps of steepest descent minimization followed by 10 steps of conjugate 
gradient minimization. The potential energy at the beginning of minimization was -1554.76 kJ/mol, while, 
at the end of the process, it was calculated as -14035.22 kJ/mol. There were no any intramolecular Clashes 
detected after the minimization process. Likewise, the physiochemical properties of the model were 
analyzed in Procheck webserver.  The overall quality analysis of the model seemed to be good. There were 
no residues observed in the disallowed regions, 3 out of 277 residues were found in generously allowed 
regions, 27 in additional allowed regions while 218 in most favored regions of Ramachandran plot. The 
detailed result of Ramachandran plot analysis from the program is given in Appendix V. 
Similarly, the Pentraxin domain of zebrafish CA VI was modeled using human SAP (4AVS) as the template 
in Modeller GUI in Chimera. The Modeller generated five homology models with the scores for each. And, 
the RMSDs with template structure and intramolecular Clashes were calculated by Matchmaker and Find 
Clashes/Contacts tools respectively in Chimera. The scores of the analysis are given in Table 5-3 on the 
basis of which the best model was chosen with the same criteria as for the CA VI domain explained above. 
The model #1.3 was chosen as the best model for further analyses. The selected model was subsequently 
subjected to energy minimization with 100 steps of steepest descent minimization followed by 10 steps 
of conjugate gradient minimization. The initial potential energy of the model was measured to be 7090.57 
kJ/mol, while, after the minimization, it was found to be -2168.71 kJ/mol. The intramolecular Clashes 
reduced to 3 from 41 after the local energy minimization. The minimized structure was evaluated for 
physiochemical properties in Procheck webserver. The quality analysis showed 87.7% of residues were in 
the most favored regions, 9.4% in additional allowed regions, 2.3% in generously allowed regions and 1 
residue found in disallowed region of the Ramachandran plot. The detailed graphical Ramachandran plot 
is given in Appendix VI. 
 
 
 
 
 
 
 
 
Model GA341 zDOPE RMSD Clashes 
#1.1 1.00 -0.57 0.236 71 
#1.2 1.00 -0.60 0.277 90 
#1.3 1.00 -0.51 0.235 67 
#1.4 1.00 -0.70 0.254 45 
#1.5 1.00 -0.63 0.303 58 
Table 5-2. Structural analysis scores of five comparative 
models of CA VI domain 
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Model GA341 zDOPE RMSD Clashes 
#1.1 1.00 -0.89 0.289 65 
#1.2 1.00 -0.80 0.315 51 
#1.3 1.00 -0.93 0.288 41 
#1.4 1.00 -0.82 0.348 60 
#1.5 1.00 -0.88 0.295 53 
Table 5-3. Structural analysis scores of five comparative 
models of Pentraxin domain. 
 
Figure 5-7. [A] The superimposition of 3FE4 (cyan) and zebrafish CA VI model (blue) structures, showing direct view of the 
active site; [B] The magnification of the active site region highlighting the 3 Histidines of hCAVI (green) and zebrafishCAVI 
(magenta) actively involved in coordinating with the metal ion (red); [C] The superimposition of 4AVS (cyan) and zebrafish 
PTX domain model (blue) structures, the Cysteine are displayed; [D] The magnification of the region showing the Cysteine 
residues in zebrafish PTX domain (model #1.5), focusing on the extra pair of Cys residues (Cys495, Cys526, zebrafish CAVI 
numbering) conserved only in CA VI related PTX, which may form disulfide bridge. 
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The models of CA VI and PTX domains after their quality assessment, was subjected to docking in 
HADDOCK. For input data required in docking, the information were predicted through CPORT interface 
prediction tool. From the list of interface residues predicted by CPORT, the residues lying in the C-terminal 
face of the CA VI domain and N-terminal face of the PTX domain were selected as it is highly likely that 
these faces would interact and also help in reducing number of sampling during the docking procedure. 
The parameters for active and passive residues thus selected for CA VI and PTX domains are as follows. 
The active residues predicted by CPORT that were selected from the C-terminus face of CA VI domain are 
D120, L121, E122, G288, M289, C290, E294, L307, S308, L309, D310 and the passive residues are D131, 
G132, G172, G287, E293, A297, S304, L305. Similarly for Pentraxin domain, the active residues selected 
from the N-terminus face of the domain are P330, L331, L512, S513, L514, Y515, G516, Q519, G522 and 
passive residues are K325, Q326, P327, I328, N347, T510, Q511, G517, V518, L520, Q521, E523. These 
active and passive residues are visualized in the structure of CA VI and Pentraxin domains in Figure 5-9. 
With the docking parameters in place, the two domains of zebrafish CA VI were assigned for docking in 
HADDOCK webserver. Normally, the docking process takes about 5 hours if there is not a queue in the 
server. The docking experiment projected ensembles of 127 models in 10 clusters that represented 63.5% 
of the water-refined models reliable according to HADDOCK. The HADDOCK score of the best cluster was 
-115.9 +/- 5.2 with a cluster size of 9 and Z-score of -2.5. The details about the scores are given in Figure 
5-8. The Z-score of a cluster indicates how many standard deviation it is located from the average in terms 
of score, the more negative the better. A top model from this cluster with the lowest (best) score was 
chosen for further visualization and interpretation. The pseudo contacts such as Vander Waal’s force, 
hydrophobic bonds were calculated between the two different domains and found to be 155 pseudo 
contacts, the parameters of this analysis is shown in Appendix VIII. The dropbox link to the pdb file of the 
docked complex molecule is provided in Appendix IX. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-8. HADDOCK score details of the best cluster from the docking experiment 
of CA VI and PTX domain of zebrafish. 
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Figure 5-9. The CA VI (first row) and Pentraxin (second row) domains are visualized in three angles and the surface coloration 
is done based on CPORT prediction. The first column of CA VI domain is its C-terminal face and Pentraxin domain is its N-
terminal face. The second and third column depicts the protein rotated 120’ along vertical axis. The red color is for active 
residues, green for passive residues and blue for no predictions from CPORT. 
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Figure 5-10. The visualization of the structure of docked complex of zebrafish CA VI with Pentraxin. The 2nd column is the 
horizontally rotated orientation of 1st column. The active site Histidines are shown in yellow.  [A] The ribbon representation 
of the whole complex, CA VI domain in tan and PTX domain in cyan. [B] The magnification at the interface region of the 
docked complex. Interface residues from CA VI domain are in red, while from PTX domain are in green and the faint lines 
in yellow represents the pseudobonds. [C] Surface representation of the complex, the surface lying on the interface regions 
are colored red and green for CA VI and PTX domains respectively. 
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6 Discussion 
6.1 The transmembrane CAs have possible secondary roles in nucleus 
All the transmembrane CAs are destined to extracellular location while them possessing the 
transmembrane helices in their sequence would mean their final targeted destination would be in the cell 
membrane. As described in literature as well as from the topology prediction of TMHMM, the catalytic CA 
domain of the transmembrane CAs lie outside the cell, followed by its membrane-spanning 
transmembrane helix anchoring the enzyme on the cell membrane, and finally a small extension of C-
terminal fragment or cytoplasmic domain lying inside the cell. All those sequences in which secretory 
peptide were not observed were the bad-quality assigned sequences, and most of those were either 
lacking the N-terminal presequence portion completely or the presequences were of bad quality that 
looked completely different from the other sequences. So it is plausible to state that these were merely 
just mispredictions caused due to bad-quality of the sequences. Hence, it is very evident to state that the 
transmembrane CAs are localized primarily to the plasma membrane of the cell. However, another type 
of signals that were detected mostly in the transmembrane and cytoplasmic regions of the sequences give 
an insight to the possible secondary localization of the transmembrane CAs. Although there were high 
degree of variation of the nucleo-cytoplasmic signal predicted among the analyzed sequences, such as 
some sequences having very strong signals while others having faint to no signals predicted at all, the 
patterns are clearly visible while inspecting the MSA visually. The signal motifs predicted very strongly in 
many of the sequences are highly if not fully conserved among all the analyzed sequences. The weak or 
no prediction in some sequences might have been caused due to various constraints the algorithms of the 
programs had to deal with in different sequences.  
Though the possible function of the transmembrane CAs in nucleus and/or in what kind of situations do 
they get transported into the nucleus are yet to be discovered that would require a design of different 
laboratory-based studies, but from the results of nucleo-cytoplasmic predictions obtained in this thesis, 
we can at least interpret how the transport of proteins that are almost locked in the phospholipid bilayer 
of the plasma membrane would occur. From the observation, it is clearly observed that the NLS motifs 
are located in the cytoplasmic portion, just where the transmembrane region ends and the cytoplasmic 
region starts. It is plausible to expect that the nuclear transporting proteins such as Importins would have 
quite trivial access for recognizing these signals that are lying in the cytoplasmic area and carrying out the 
necessary mechanisms to pull out the proteins out of the cell membrane and transport into the nucleus 
where their undiscovered role would be awaiting. And the NES motifs lying in the transmembrane portions 
would also have no any hindrance for the Exportins from recognizing and binding with, since the 
transmembrane helices of the enzymes are not bound with or sealed inside any cell membrane as they 
are inside nucleus now. 
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Figure 6-1. The C-terminal portion from the MSA of orthologues of CA IX and the predicted NLS (green) and NES (pink) sites highlighted 
in the respective sequences. The transmembrane and cytoplasmic domain boundary are indicated by the figures annotated below the 
alignment. 
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Figure 6-2. The portion from C-terminal region of the MSA of CA XII and the predicted NLS (green) and NES (pink) highlighted in 
respective sequences. The transmembrane and cytoplasmic domain boundary are depicted by figures below the alignment. 
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Figure 6-3. The portion from the C-terminal region of MSA of CA XIV orthologous sequences. The predicted NLS (green) and NES (pink) sites 
are highlighted. And the transmembrane and cytoplasmic domain boundary are depicted by figures below the alignment. 
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6.2 The CA XII and CA XIV can form dimers 
The sequence motifs GxxxG and GxxxS have been identified as the signatures which mediate the 
dimerization in transmembrane alpha helices forming coiled-coil helices. The same motifs have been 
demonstrated to mediate helix-helix association in the NMR structures of Glycophorin A dimer 
(MacKenzie, Prestegard, and Engelman 1997; Smith et al. 2001). Likewise, the isologous dimer 
architecture of human CA XII dimer structure in x-ray crystallography study was also speculated to persist 
within the transmembrane segment of the enzyme where the sequence motifs are present (Whittington 
et al. 2001).  The conservation of the sequence motifs GxxxG and GxxxS observed in the transmembrane 
domains of most of the orthologous sequences of CA XII and CA XIV would suggest that these isozymes 
can also persevere as a dimer. The stabilization of dimeric form of the transmembrane CAs, also including 
CA IX where Cys disulfide bridge mediates the dimerism, would support our hypothesis that these groups 
of CA isozymes have some role in the nucleus which probably would have something to do with DNA or 
else just a normal CA activity inside nucleus. From the proposed model of full-length CA IX and CA XII 
structures as illustrated by (Alterio et al. 2009) and (Whittington et al. 2001) and CA XIV in Figure 6-4, it is 
visually reflective that the 
architecture of the transmembrane 
helix nearly resembles the 
geometry of coiled-coil helices. The 
coiled-coil helices are known to 
have an important function in DNA-
binding proteins such as 
transcription factors where the two 
helical secondary structure would 
interlock onto the major groove of 
DNA molecules. If our hypothesis of 
nuclear localization of 
transmembrane CAs, as predicted 
by the bioinformatics programs, are 
in fact true and the dimeric 
organization of these enzymes are 
stable, then the dimeric 
architecture of transmembrane 
helix would possibly function as 
coiled-coil helix for binding with 
DNA in the nucleus, which would 
mean that the transmembrane CAs 
might have a role as transcription 
factor mediating transcription of 
some unsuspecting proteins, 
maybe those proteins that have 
important role in tumorigenesis. 
However, these are just our 
hypothesis. 
  
 
Figure 6-4. Schematic representation of a hypothetical model of full length CA XIV dimer, 
CA XIV structure from pdb: 4LU3 (Alterio et al. 2014). The two extracellular catalytic 
domains are shown in magenta and cyan along with active site Histidines (red) and Zinc 
(blue). The extra-drawings of transmembrane helix (yellow) and cytoplasmic domain 
(orange spheres) and the plasma membrane was derived from (Whittington et al. 2001). 
The dimerization motifs GxxxG and GxxxS in the transmembrane helices would mediate 
the dimer organization in the two moieties. 
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6.3 The zebrafish CA VI has double domain and may exist as oligomer 
The novel type of domain discovered in the CA VI of non-mammalian vertebrates has provided new insight 
into the CA evolution of the higher animals. This novel domain that are related to Pentraxins is also new 
to the Pentraxin family of proteins which have never been characterized before. Though not yet clearly 
known, the Pentraxin proteins potentially have some roles in the immune system. These facts make it 
interesting that the CA VI - related Pentraxins might also possess a potential functionality in the immune 
system in addition to their regular CA activity. And moreover, a structural insight would provide 
researchers to speculate or investigate any hypothesis regarding the undiscovered physiological role of 
these isozymes. The computer-generated model of full CA VI of zebrafish along with the associated 
Pentraxin domain is the first ever 3-D model of any CA VI isozyme which have the Pentraxin domain in its 
sequence. The organism zebrafish was chosen here in this study as it is a model organism that has been 
popularly in the interest of molecular biologists and hence it could serve as an important model for any 
structural interpretation for the researchers. As observed from the docking experiment performed 
computationally in this thesis, the model of CA VI with Pentraxin domain looks to be stable since the 
catalytic pocket of CA domain is as equally accessible as it would be for the lone CA domain, as well as the 
N-linked glycosylation sites of both Pentraxin and CA VI domains also lie on the extreme surfaces of the 
bi-domain structure exposing it to the sugar molecules. This could provide evidence confirming that the 
enzyme is functional as a double domain protein in zebrafish. Adding to this, the experimental structures 
of the Pentraxin proteins in the PDB database are mostly found to exist as oligomeric organizations of 
three or five or ten monomers (Chen et al. 2015; Kolstoe et al. 2014; Ramadan et al. 2002). Hence, it is 
plausible to say that the Pentraxin domain-bearing CA VI proteins in non-mammalian vertebrates might 
also organize in the similar fashion in nature. Then, the Pentraxin domains would organize as a certain 
oligomer while the CA VI domains would lie hanging from the Pentraxin domains around the 
circumference of oligomer structure. 
 
Figure 6-5. An ideal pentameric model of the zebrafish CA VI+PTX complex, as constructed by aligning 5 units with each 
of the subunit of human SAP structure (4AVS). Each particular units are in distinct colors (cyan, tan, magenta, green, 
purple), the interface regions between the CA VI and PTX domains are in black, the N-glycosylation sites are shown in 
red. 
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6.4 Possible sources of error 
The main task in this study involved the structural modeling of a protein through the computational 
approach. The homology modeling as well as docking themselves are not the ultimate solutions to 
determine a structural model of any macromolecules, rather it is a method to predict a near-close 
naturally resembling structure. Although, the computational approaches have gone through major 
development and today’s softwares are far more powerful and reliable in performing such tasks, but they 
still require numerous improvements from methodological point of view. Relying completely on 
computational model for most interpretation is not recommended, however, the models produced from 
such methods can still make a good use in providing idea to experimental biologists regarding how their 
experiment setup could be designed so as to minimize chances of any unsuccessful attempt. The interface 
predicting tool CPORT also basically over-predicts the interface residues of the protein structure, which 
could be another issue that can cause unnecessary sampling while docking resulting in poorly scored 
structures. Hence, a manual intervention was done mainly to omit those parts from the over predicted 
interface residues which would normally do not seem to interact i.e. the either end and start terminal 
surfaces of each interacting molecules would face each other directly while interaction, thus only those 
residues from C-terminal surface of CA VI domain and N-terminal surface of Pentraxin domain were 
selected. This enforcement is completely hypothetical and does not guarantee the actual orientation, 
however, it is so far a near possible orientation. Nevertheless, the docked model of the full length of 
zebrafish CA VI with Pentraxin can help researchers in our research group and also other groups working 
on this protein into studying various structural properties in the absence of its experimental structure. 
Moreover, this computational model is a first ever model of any CA isozyme having a recently discovered 
novel Pentraxin domain, which in itself is a new member in the Pentraxin family of proteins. 
The possibility of errors in the sequence analysis part was clearly observed. Even though it was observed 
from the sequence alignment that the motifs predicted very strongly in most sequences was conserved 
throughout all the orthologues, there were a considerable amount of mispredictions clearly seen in the 
highly conserved motifs. There could be several reasons behind this that has to do with the technicality 
of the algorithms of the program. It also depends on how input sequences were fed in the program such 
as in NetNES, only last 60 amino acids residues from each of the proteins were fed so as to reduce the 
restrain for the program to have to deal with lesser amount of data. However, the mispredictions do not 
mean that the signals are definitely not present in those sequences. Again, the bioinformatics tools are 
mostly used for predicting, not as an ultimate confirmation solution. Henceforth, experimental 
investigations to the nucleo-cytoplasmic localization of transmembrane CAs should be greatly anticipated 
in the future research on these isozymes. 
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7 Conclusion 
The primary goal of this study was to identify nucleo-cytoplasmic localization signals in the 
transmembrane CAs: CA IX, CA XII and CA XIV. The bioinformatics tools NetNES and NucPred were used 
to predict the NES and NLS sequence motifs respectively in a datasets of orthologous sequences from 
vertebrate species of each isozyme form. The results obtained have given new insight into the possible 
secondary roles of the transmembrane family of CAs. The elusiveness of NES and NLS signals that were 
lying hidden to researchers for decades have been identified from not just a single, but multiple vertebrate 
species which shows that these signals have been conserved early on evolution. Moreover, these signals 
have been identified in the transmembrane and cytoplasmic regions of these isozymes that are a distinct 
features of these isozyme family, whose functional characterization was largely lacking beside its function 
in anchoring the proteins in the cell membrane. The findings have opened a new door to investigations 
for understanding these possible nuclear roles of the transmembrane CAs that could be achieved through 
experiments. 
The other main goal of this study was to model a full-length structure of zebrafish CA VI consisting of the 
Pentraxin domain along with the regular CA domain. The both softwares MODELLER and HADDOCK are 
among the best in comparative modeling and docking macromolecules respectively. Each of the domains 
were modeled computationally through homology modeling using templates structures of their 
respective homologous proteins and subsequently docked to generate a complete model of the 
macromolecular complex of CA VI and Pentraxin enzyme of zebrafish Danio rerio, an experimental model 
organism. The model of the complex would be useful for researchers to investigate structural properties 
of the CA isozyme that has the novel Pentraxin domain and may help to interpret the functional role that 
Pentraxin domain could interplay in normal functionality of secretory CA VI isozyme of non-mammalian 
vertebrates. 
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9 Appendices 
 
Appendix I – TargetP results 
A. TargetP results of CA IX orthologues 
TargetP v1.1 prediction results 
Number of query sequences:  33 
Cleavage site predictions included. 
Using NON-PLANT networks. 
Name Len mTP SP other Loc RC TPlen 
Homo_sapiens 459 0.007 0.981 0.118 S 1 37 
Pan_troglodytes 453 0.007 0.98 0.114 S 1 37 
Pongo_abelii 465 0.01 0.922 0.275 S 2 37 
Nomascus_leucogenys 447 0.009 0.966 0.166 S 2 37 
Macaca_mulatta 447 0.007 0.98 0.121 S 1 37 
Callithrix_jacchus 451 0.007 0.981 0.122 S 1 37 
Otolemur_garnettii 455 0.008 0.985 0.103 S 1 37 
Felis_catus 454 0.011 0.921 0.192 S 2 37 
Procavia_capensis 451 0.006 0.992 0.063 S 1 37 
Equus_caballus 443 0.006 0.957 0.242 S 2 37 
Loxodonta_africana 455 0.014 0.932 0.159 S 2 37 
Echinops_telfairi 454 0.038 0.543 0.432 S 5 36 
Bos_taurus 449 0.015 0.922 0.154 S 2 37 
Ailuropoda_melanoleuca 449 0.008 0.92 0.255 S 2 39 
Canis_familiaris 440 0.008 0.97 0.16 S 1 37 
Sus_scrofa 442 0.007 0.973 0.141 S 1 37 
Ochotona_princeps 437 0.014 0.912 0.21 S 2 37 
Oryctolagus_cuniculus 440 0.018 0.881 0.208 S 2 36 
Mus_musculus 437 0.012 0.904 0.256 S 2 31 
Rattus_norvegicus 437 0.006 0.982 0.117 S 1 31 
Ictidomys_tridecemlineatus 437 0.004 0.986 0.115 S 1 33 
Monodelphis_domestica 456 0.035 0.924 0.066 S 1 33 
Myotis_lucifugus 434 0.01 0.871 0.29 S 3 37 
Sorex_araneus 265 0.455 0.099 0.451 * 5 - 
Pteropus_vampyrus 434 0.006 0.987 0.095 S 1 35 
Dipodomys_ordii 433 0.005 0.987 0.106 S 1 33 
Cavia_porcellus 448 0.04 0.613 0.539 S 5 50 
Sarcophilus_harrisii 455 0.66 0.368 0.073 * 4 - 
Meleagris_gallopavo 314 0.158 0.074 0.837 _ 2 - 
Gallus_gallus 367 0.219 0.709 0.023 S 3 21 
Ficedula_albicollis 367 0.122 0.851 0.016 S 2 21 
Latimeria_chalumnae 368 0.025 0.943 0.076 S 1 22 
Danio_rerio 384 0.028 0.937 0.056 S 1 22 
cutoff  0.78 0 0.73    
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B. TargetP results of CA XII orthologues 
TargetP v1.1 prediction results 
Number of query sequences:  35 
Cleavage site predictions included. 
Using NON-PLANT networks. 
Name Len mTP SP other Loc RC TPlen 
Homo_sapiens 354 0.078 0.805 0.041 S 2 24 
Gorilla_gorilla 354 0.078 0.805 0.041 S 2 24 
Pan_troglodytes 354 0.078 0.805 0.041 S 2 24 
Pongo_abelii 354 0.077 0.812 0.041 S 2 24 
Nomascus_leucogenys 354 0.076 0.766 0.054 S 2 24 
Macaca_mulatta 354 0.039 0.877 0.068 S 1 24 
Microcebus_murinus 355 0.042 0.865 0.068 S 2 24 
Mus_musculus 354 0.328 0.739 0.016 S 3 24 
Rattus_norvegicus 354 0.025 0.93 0.082 S 1 24 
Oryctolagus_cuniculus 355 0.206 0.815 0.029 S 2 24 
Tursiops_truncatus 356 0.039 0.917 0.063 S 1 24 
Equus_caballus 355 0.05 0.867 0.064 S 1 24 
Mustela_putorius_furo 355 0.028 0.955 0.039 S 1 24 
Pteropus_vampyrus 356 0.027 0.897 0.081 S 1 24 
Monodelphis_domestica 358 0.058 0.906 0.037 S 1 27 
Sarcophilus_harrisii 356 0.056 0.91 0.056 S 1 25 
Gallus_gallus 347 0.108 0.836 0.035 S 2 26 
Meleagris_gallopavo 357 0.094 0.698 0.09 S 2 31 
Callithrix_jacchus 319 0.082 0.175 0.853 _ 2 - 
Otolemur_garnettii 320 0.074 0.154 0.874 _ 2 - 
Cavia_porcellus 310 0.086 0.14 0.849 _ 2 - 
Ictidomys_tridecemlineatus 320 0.097 0.157 0.782 _ 2 - 
Ailuropoda_melanoleuca 351 0.047 0.761 0.21 S 3 21 
Bos_taurus 321 0.047 0.225 0.89 _ 2 - 
Myotis_lucifugus 319 0.078 0.212 0.814 _ 2 - 
Felis_catus 359 0.108 0.059 0.862 _ 2 - 
Canis_familiaris 309 0.097 0.133 0.843 _ 2 - 
Loxodonta_africana 322 0.1 0.124 0.839 _ 2 - 
Ficedula_albicollis 320 0.053 0.09 0.931 _ 1 - 
Pelodiscus_sinensis 326 0.057 0.216 0.867 _ 2 - 
Anas_platyrhynchos 343 0.021 0.881 0.108 S 2 17 
Xenopus_tropicalis 337 0.015 0.95 0.089 S 1 18 
Latimeria_chalumnae 335 0.091 0.907 0.033 S 1 20 
Tetraodon_nigroviridis 357 0.313 0.21 0.208 * 5 - 
Takifugu_rubripes 331 0.044 0.068 0.95 _ 1 - 
cutoff 0.78 0 0.73     
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C. TargetP results of CA XIV 
TargetP v1.1 prediction results 
Number of query sequences:  33 
Cleavage site predictions included. 
Using NON-PLANT networks. 
Name Len mTP SP other Loc RC TPlen 
Homo_sapiens 337 0.019 0.921 0.133 S 2 18 
Gorilla_gorilla 337 0.019 0.921 0.134 S 2 18 
Pan_troglodytes 337 0.02 0.92 0.132 S 2 18 
Nomascus_leucogenys 337 0.019 0.921 0.133 S 2 18 
Macaca_mulatta 337 0.019 0.921 0.133 S 2 18 
Callithrix_jacchus 337 0.019 0.921 0.131 S 2 18 
Otolemur_garnettii 336 0.019 0.928 0.123 S 1 18 
Ictidomys_tridecemlineatus 338 0.02 0.921 0.133 S 2 18 
Mus_musculus 337 0.028 0.898 0.114 S 2 15 
Rattus_norvegicus 337 0.028 0.904 0.113 S 2 15 
Cavia_porcellus 337 0.028 0.883 0.185 S 2 15 
Dipodomys_ordii 337 0.027 0.892 0.161 S 2 16 
Loxodonta_africana 337 0.021 0.921 0.134 S 2 16 
Procavia_capensis 326 0.041 0.784 0.294 S 3 15 
Pteropus_vampyrus 337 0.018 0.947 0.117 S 1 18 
Felis_catus 336 0.017 0.947 0.111 S 1 18 
Bos_taurus 336 0.017 0.949 0.109 S 1 18 
Ailuropoda_melanoleuca 336 0.016 0.955 0.095 S 1 18 
Mustela_putorius_furo 336 0.017 0.953 0.099 S 1 18 
Ochotona_princeps 337 0.03 0.849 0.165 S 2 17 
Oryctolagus_cuniculus 337 0.02 0.941 0.119 S 1 18 
Sarcophilus_harrisii 340 0.037 0.88 0.182 S 2 16 
Monodelphis_domestica 340 0.028 0.887 0.185 S 2 16 
Xenopus_tropicalis 344 0.067 0.777 0.187 S 3 17 
Latimeria_chalumnae 342 0.016 0.97 0.057 S 1 29 
Xiphophorus_maculatus 344 0.112 0.501 0.349 S 5 18 
Dasypus_novemcinctus 330 0.108 0.181 0.773 _ 3 - 
Vicugna_pacos 314 0.053 0.041 0.956 _ 1 - 
Myotis_lucifugus 334 0.019 0.949 0.088 S 1 18 
Canis_familiaris 343 0.89 0.022 0.154 M 2 22 
Macropus_eugenii 320 0.057 0.058 0.948 _ 1 - 
Oryzias_latipes 318 0.037 0.147 0.946 _ 2 - 
Oreochromis_niloticus 394 0.011 0.984 0.051 S 1 20 
cutoff 0.78 0 0.73     
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Appendix II – TMHMM results 
 
A. TMHMM results of CA IX 
      start_last_60 size_IC_domain TM_size 
Homo_sapiens len=459 ExpAA=26.92      First60=4.97     PredHel=1        Topology=o411-433i 12 26 22 
Pan_troglodytes len=453 ExpAA=26.97 First60=5.00 PredHel=1 Topology=o405-427i 12 26 22 
Pongo_abelii len=465 ExpAA=22.74 First60=0.87 PredHel=1 Topology=o417-439i 12 26 22 
Nomascus_leucogenys len=447 ExpAA=26.90 First60=4.89 PredHel=1 Topology=o399-421i 12 26 22 
Macaca_mulatta len=447 ExpAA=27.54 First60=5.29 PredHel=1 Topology=o399-421i 12 26 22 
Callithrix_jacchus len=451 ExpAA=23.84 First60=2.02 PredHel=1 Topology=o403-425i 12 26 22 
Otolemur_garnettii len=455 ExpAA=29.54 First60=7.43 PredHel=1 Topology=o405-427i 10 28 22 
Felis_catus len=454 ExpAA=21.90 First60=0.15 PredHel=1 Topology=o404-426i 10 28 22 
Procavia_capensis len=451 ExpAA=23.38 First60=1.77 PredHel=1 Topology=o403-425i 12 26 22 
Equus_caballus len=443 ExpAA=21.30 First60=0.04 PredHel=1 Topology=o393-415i 10 28 22 
Loxodonta_africana len=455 ExpAA=21.56 First60=0.06 PredHel=1 Topology=o404-426i 9 29 22 
Echinops_telfairi len=454 ExpAA=21.62 First60=0.00 PredHel=1 Topology=o407-429i 13 25 22 
Bos_taurus len=449 ExpAA=26.50 First60=4.72 PredHel=1 Topology=o399-421i 10 28 22 
Ailuropoda_melanoleuca len=449 ExpAA=22.29 First60=0.47 PredHel=1 Topology=o397-419i 8 30 22 
Canis_familiaris len=440 ExpAA=21.55 First60=1.28 PredHel=1 Topology=o415-433i 35 7 18 
Sus_scrofa len=442 ExpAA=28.32 First60=6.50 PredHel=1 Topology=o392-414i 10 28 22 
Ochotona_princeps len=437 ExpAA=22.46 First60=0.29 PredHel=1 Topology=o390-412i 13 25 22 
Oryctolagus_cuniculus len=440 ExpAA=21.81 First60=0.02 PredHel=1 Topology=o390-412i 10 28 22 
Mus_musculus len=437 ExpAA=21.60 First60=0.15 PredHel=1 Topology=o387-409i 10 28 22 
Rattus_norvegicus len=437 ExpAA=29.42 First60=8.43 PredHel=1 Topology=o387-409i 10 28 22 
Ictidomys_tridecemlineatus len=437 ExpAA=40.25 First60=18.24 PredHel=2 Topology=i7-29o387-409i 10 28 22 
Monodelphis_domestica len=456 ExpAA=23.21 First60=1.77 PredHel=1 Topology=o407-429i 11 27 22 
Myotis_lucifugus len=434 ExpAA=22.60 First60=0.64 PredHel=1 Topology=o384-406i 10 28 22 
Sorex_araneus len=265 ExpAA=21.43 First60=0.00 PredHel=1 Topology=o219-238i 14 27 19 
Pteropus_vampyrus len=434 ExpAA=35.78 First60=14.05 PredHel=1 Topology=o386-408i 12 26 22 
Dipodomys_ordii len=433 ExpAA=29.13 First60=7.44 PredHel=1 Topology=o385-407i 12 26 22 
Cavia_porcellus len=448 ExpAA=30.50 First60=9.11 PredHel=1 Topology=o398-420i 10 28 22 
Sarcophilus_harrisii len=455 ExpAA=32.98 First60=11.05 PredHel=1 Topology=o407-429i 12 26 22 
Meleagris_gallopavo len=314 ExpAA=22.41 First60=0.09 PredHel=1 Topology=o264-286i 10 28 22 
Gallus_gallus len=367 ExpAA=21.98 First60=0.12 PredHel=1 Topology=o316-338i 9 29 22 
Ficedula_albicollis len=367 ExpAA=21.86 First60=0.07 PredHel=1 Topology=o317-339i 10 28 22 
Latimeria_chalumnae len=368 ExpAA=22.76 First60=0.57 PredHel=1 Topology=o319-341i 11 27 22 
Danio_rerio len=384 ExpAA=22.46 First60=0.02 PredHel=1 Topology=o326-348i 2 36 22 
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B. TMHMM results of CA XII orthologues 
      start_last_60 size_IC TM_size 
Homo_sapiens len=354 ExpAA=23.68 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Gorilla_gorilla len=354 ExpAA=23.68 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Pan_troglodytes len=354 ExpAA=23.68 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Pongo_abelii len=354 ExpAA=23.69 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Nomascus_leucogenys len=354 ExpAA=23.64 First60=0.01 PredHel=1 Topology=o305-327i 11 27 22 
Macaca_mulatta len=354 ExpAA=24.25 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Microcebus_murinus len=355 ExpAA=23.64 First60=0.00 PredHel=1 Topology=o305-327i 10 28 22 
Mus_musculus len=354 ExpAA=23.67 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Rattus_norvegicus len=354 ExpAA=23.42 First60=0.00 PredHel=1 Topology=o305-327i 11 27 22 
Oryctolagus_cuniculus len=355 ExpAA=23.52 First60=0.05 PredHel=1 Topology=o304-326i 9 29 22 
Tursiops_truncatus len=356 ExpAA=23.19 First60=0.00 PredHel=1 Topology=o306-328i 10 28 22 
Equus_caballus len=355 ExpAA=23.03 First60=0.00 PredHel=1 Topology=o305-327i 10 28 22 
Mustela_putorius_furo len=355 ExpAA=25.79 First60=1.51 PredHel=1 Topology=o305-327i 10 28 22 
Pteropus_vampyrus len=356 ExpAA=23.73 First60=0.01 PredHel=1 Topology=o305-327i 9 29 22 
Monodelphis_domestica len=358 ExpAA=25.90 First60=2.72 PredHel=1 Topology=o308-330i 10 28 22 
Sarcophilus_harrisii len=356 ExpAA=23.64 First60=0.47 PredHel=1 Topology=o306-328i 10 28 22 
Gallus_gallus len=347 ExpAA=24.92 First60=2.22 PredHel=1 Topology=o295-317i 8 30 22 
Meleagris_gallopavo len=357 ExpAA=24.97 First60=1.28 PredHel=1 Topology=o305-327i 8 30 22 
Callithrix_jacchus len=319 ExpAA=23.20 First60=0.00 PredHel=1 Topology=o270-292i 11 27 22 
Otolemur_garnettii len=320 ExpAA=23.63 First60=0.00 PredHel=1 Topology=o271-293i 11 27 22 
Cavia_porcellus len=310 ExpAA=23.06 First60=0.00 PredHel=1 Topology=o259-281i 9 29 22 
Ictidomys_tridecemlineatus len=320 ExpAA=22.96 First60=0.00 PredHel=1 Topology=o271-293i 11 27 22 
Ailuropoda_melanoleuca len=351 ExpAA=24.30 First60=0.00 PredHel=1 Topology=o302-324i 11 27 22 
Bos_taurus len=321 ExpAA=22.96 First60=0.00 PredHel=1 Topology=o271-293i 10 28 22 
Myotis_lucifugus len=319 ExpAA=24.04 First60=0.00 PredHel=1 Topology=o269-291i 10 28 22 
Felis_catus len=359 ExpAA=23.75 First60=0.00 PredHel=1 Topology=o309-331i 10 28 22 
Canis_familiaris len=309 ExpAA=22.94 First60=0.01 PredHel=1 Topology=o258-280i 9 29 22 
Loxodonta_africana len=322 ExpAA=23.54 First60=0.00 PredHel=1 Topology=o271-293i 9 29 22 
Ficedula_albicollis len=320 ExpAA=22.99 First60=0.00 PredHel=1 Topology=o266-288i 6 32 22 
Pelodiscus_sinensis len=326 ExpAA=27.08 First60=0.00 PredHel=1 Topology=o274-296i 8 30 22 
Anas_platyrhynchos len=343 ExpAA=22.93 First60=0.01 PredHel=1 Topology=o290-312i 7 31 22 
Xenopus_tropicalis len=337 ExpAA=23.46 First60=0.49 PredHel=1 Topology=o284-306i 7 31 22 
Latimeria_chalumnae len=335 ExpAA=26.43 First60=3.41 PredHel=1 Topology=o282-304i 7 31 22 
Tetraodon_nigroviridis len=357 ExpAA=22.94 First60=0.23 PredHel=1 Topology=o308-330i 11 27 22 
Takifugu_rubripes len=331 ExpAA=22.92 First60=0.00 PredHel=1 Topology=o280-302i 9 29 22 
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C. TMHMM results of CA XIV orthologues 
      start_last_60 size_IC TM_size 
Homo_sapiens len=337 ExpAA=22.26 First60=0.04 PredHel=1 Topology=o290-312i 13 25 22 
Gorilla_gorilla len=337 ExpAA=22.22 First60=0.02 PredHel=1 Topology=o290-312i 13 25 22 
Pan_troglodytes len=337 ExpAA=22.31 First60=0.11 PredHel=1 Topology=o290-312i 13 25 22 
Nomascus_leucogenys len=337 ExpAA=22.06 First60=0.04 PredHel=1 Topology=o290-312i 13 25 22 
Macaca_mulatta len=337 ExpAA=22.27 First60=0.04 PredHel=1 Topology=o290-312i 13 25 22 
Callithrix_jacchus len=337 ExpAA=22.10 First60=0.04 PredHel=1 Topology=o290-312i 13 25 22 
Otolemur_garnettii len=336 ExpAA=22.67 First60=0.06 PredHel=1 Topology=o289-311i 13 25 22 
Ictidomys_tridecemlineatus len=338 ExpAA=22.37 First60=0.16 PredHel=1 Topology=o291-313i 13 25 22 
Mus_musculus len=337 ExpAA=22.44 First60=0.02 PredHel=1 Topology=o290-312i 13 25 22 
Rattus_norvegicus len=337 ExpAA=22.35 First60=0.05 PredHel=1 Topology=o290-312i 13 25 22 
Cavia_porcellus len=337 ExpAA=22.20 First60=0.00 PredHel=1 Topology=o290-312i 13 25 22 
Dipodomys_ordii len=337 ExpAA=22.41 First60=0.03 PredHel=1 Topology=o290-312i 13 25 22 
Loxodonta_africana len=337 ExpAA=22.63 First60=0.05 PredHel=1 Topology=o290-312i 13 25 22 
Procavia_capensis len=326 ExpAA=22.51 First60=0.00 PredHel=1 Topology=o290-312i 24 14 22 
Pteropus_vampyrus len=337 ExpAA=22.03 First60=0.01 PredHel=1 Topology=o291-313i 14 24 22 
Felis_catus len=336 ExpAA=22.29 First60=0.05 PredHel=1 Topology=o290-312i 14 24 22 
Bos_taurus len=336 ExpAA=22.39 First60=0.12 PredHel=1 Topology=o290-312i 14 24 22 
Ailuropoda_melanoleuca len=336 ExpAA=22.14 First60=0.04 PredHel=1 Topology=o290-312i 14 24 22 
Mustela_putorius_furo len=336 ExpAA=22.09 First60=0.05 PredHel=1 Topology=o290-312i 14 24 22 
Ochotona_princeps len=337 ExpAA=22.29 First60=0.01 PredHel=1 Topology=o290-312i 13 25 22 
Oryctolagus_cuniculus len=337 ExpAA=22.80 First60=0.16 PredHel=1 Topology=o290-312i 13 25 22 
Sarcophilus_harrisii len=340 ExpAA=22.25 First60=0.00 PredHel=1 Topology=o292-314i 12 26 22 
Monodelphis_domestica len=340 ExpAA=22.41 First60=0.00 PredHel=1 Topology=o292-314i 12 26 22 
Xenopus_tropicalis len=344 ExpAA=22.99 First60=0.00 PredHel=1 Topology=o294-316i 10 28 22 
Latimeria_chalumnae len=342 ExpAA=45.92 First60=22.76 PredHel=2 Topology=i2-24o293-315i 11 27 22 
Xiphophorus_maculatus len=344 ExpAA=22.73 First60=0.00 PredHel=1 Topology=o295-317i 11 27 22 
Dasypus_novemcinctus len=330 ExpAA=22.08 First60=0.00 PredHel=1 Topology=o283-305i 13 25 22 
Vicugna_pacos len=314 ExpAA=22.55 First60=0.00 PredHel=1 Topology=o271-293i 17 21 22 
Myotis_lucifugus len=334 ExpAA=21.76 First60=0.04 PredHel=1 Topology=o289-311i 15 23 22 
Canis_familiaris len=343 ExpAA=22.52 First60=0.00 PredHel=1 Topology=o297-319i 14 24 22 
Macropus_eugenii len=320 ExpAA=22.31 First60=0.00 PredHel=1 Topology=o272-294i 12 26 22 
Oryzias_latipes len=318 ExpAA=22.59 First60=0.00 PredHel=1 Topology=o270-292i 12 26 22 
Oreochromis_niloticus len=394 ExpAA=26.94 First60=4.22 PredHel=1 Topology=o300-322i -34 72 22 
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Appendix III – NetNES output sample of human CA IX sequence 
 
 
>ENSG00000107159 - NetNES 1.1 prediction 
 
 
#Seq-Pos-Residue           ANN     HMM     NES   Predicted 
#--------------------------------------------------------- 
ENSG00000107159-1-A       0.100   0.000   0.000      - 
ENSG00000107159-2-A       0.084   0.000   0.000      - 
ENSG00000107159-3-E       0.080   0.000   0.000      - 
ENSG00000107159-4-P       0.083   0.000   0.000      - 
ENSG00000107159-5-V       0.111   0.028   0.000      - 
ENSG00000107159-6-Q       0.075   0.028   0.000      - 
ENSG00000107159-7-L       0.335   0.071   0.000      - 
ENSG00000107159-8-N       0.082   0.071   0.000      - 
ENSG00000107159-9-S       0.091   0.071   0.000      - 
ENSG00000107159-10-C      0.095   0.071   0.000      - 
ENSG00000107159-11-L      0.121   0.248   0.008      - 
ENSG00000107159-12-A      0.096   0.244   0.008      - 
ENSG00000107159-13-A      0.217   0.244   0.000      - 
ENSG00000107159-14-G      0.070   0.244   0.000      - 
ENSG00000107159-15-D      0.076   0.244   0.000      - 
ENSG00000107159-16-I      0.517   0.356   0.586      Yes 
ENSG00000107159-17-L      0.105   0.837   0.663      Yes 
ENSG00000107159-18-A      0.109   0.837   0.666      Yes 
ENSG00000107159-19-L      0.426   0.959   1.230      Yes 
ENSG00000107159-20-V      0.084   0.850   0.724      Yes 
ENSG00000107159-21-F      0.135   0.851   0.736      Yes 
ENSG00000107159-22-G      0.084   0.756   0.545      Yes 
ENSG00000107159-23-L      0.152   0.772   0.571      Yes 
ENSG00000107159-24-L      0.132   0.336   0.138      - 
ENSG00000107159-25-F      0.122   0.306   0.048      - 
ENSG00000107159-26-A      0.399   0.051   0.000      - 
ENSG00000107159-27-V      0.163   0.053   0.000      - 
ENSG00000107159-28-T      0.078   0.028   0.000      - 
ENSG00000107159-29-S      0.082   0.028   0.000      - 
ENSG00000107159-30-V      0.082   0.036   0.000      - 
ENSG00000107159-31-A      0.076   0.023   0.000      - 
ENSG00000107159-32-F      0.116   0.023   0.000      - 
ENSG00000107159-33-L      0.126   0.020   0.000      - 
ENSG00000107159-34-V      0.075   0.016   0.000      - 
ENSG00000107159-35-Q      0.085   0.015   0.000      - 
ENSG00000107159-36-M      0.084   0.015   0.000      - 
ENSG00000107159-37-R      0.079   0.000   0.000      - 
ENSG00000107159-38-R      0.110   0.000   0.000      - 
ENSG00000107159-39-Q      0.096   0.000   0.000      - 
ENSG00000107159-40-H      0.085   0.000   0.000      - 
ENSG00000107159-41-R      0.097   0.000   0.000      - 
ENSG00000107159-42-R      0.082   0.000   0.000      - 
ENSG00000107159-43-G      0.079   0.000   0.000      - 
ENSG00000107159-44-T      0.074   0.000   0.000      - 
ENSG00000107159-45-K      0.090   0.000   0.000      - 
ENSG00000107159-46-G      0.072   0.000   0.000      - 
ENSG00000107159-47-G      0.068   0.000   0.000      - 
ENSG00000107159-48-V      0.070   0.000   0.000      - 
ENSG00000107159-49-S      0.065   0.000   0.000      - 
ENSG00000107159-50-Y      0.077   0.000   0.000      - 
ENSG00000107159-51-R      0.072   0.000   0.000      - 
ENSG00000107159-52-P      0.072   0.000   0.000      - 
ENSG00000107159-53-A      0.075   0.000   0.000      - 
ENSG00000107159-54-E      0.068   0.000   0.000      - 
ENSG00000107159-55-V      0.075   0.000   0.000      - 
ENSG00000107159-56-A      0.071   0.000   0.000      - 
ENSG00000107159-57-E      0.073   0.000   0.000      - 
ENSG00000107159-58-T      0.069   0.000   0.000      - 
ENSG00000107159-59-G      0.073   0.000   0.000      - 
ENSG00000107159-60-A      0.074   0.000   0.000      - 
// 
 
[Note: See Appendix IX for full result files]  
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Appendix IV – NucPred output sample of CA XII orthologues  
 
 
NucPred - multiple sequences 
Got 15 sequences with 5044 residues 
Calculating NucPred scores 0.59 0.59 0.57 0.63 0.62 0.60 0.53 0.57 0.55 0.53 0.47 0.53 0.51 0.49 0.42  
Running ClustalW (please be patient) 
NucPred coloured multiple alignment (warning - the alignment may be inaccurate in places because we have aligned full-length 
sequences which may have different domain organisation) 
ENSG00000118298    0.59 QLEKLQGTLFSTEEEPSKLLVQNYRALQPLNQRMVFASFIQAG-SSYTTGEMLSLGVGIL  
ENSGGOG00000017116 0.59 QLEKLQGTLFSTEEEPSKLLVQNYRAPQPLNQRMVFASFIQAG-SSYTTGEMLSLGVGIL  
ENSPTRG00000001249 0.57 QLEKLQGTLFSTEEEPSKLLVQNYRALQPLNQRMVFASFIQAG-SSYTTGEMLSLGVGIL  
ENSNLEG00000009787 0.63 QLEKLQGTLFSTEEGPSKLLVQNYRAPQPLNQRMVFASFIQGD-SPRLRSEMLSLGVGIL  
ENSMMUG00000021385 0.62 QLEKLQGTLFSTEEEPSKLLVQNYRAPQPLNQRMVFASFSQAG-SLYTTGEMLSLGVGIL  
ENSCJAG00000009756 0.60 QLEKLQETLFSTEEEPSEPLVQNYRAPQPLNQRMVFASFIQGD-SASPPGEMLSLGVGIL  
ENSOGAG00000004842 0.53 QLEMLQETLFSTEE-PSNLLAQNYRAPQPLNQRTVFASFVQVG-SLYTTGEILSLGVGIL  
ENSSTOG00000027815 0.57 QLEKLQETLFSTEEEPSEPLIQNYRAPQPLNQRTVFASFTQGDSPRLRTGEMLSLGVGIL  
ENSMUSG00000038526 0.55 QLEKLQETLSSTEEDPSEPLVQNYRVPQPLNQRTIFASFIQAG-PLYTTGEMLGLGVGIL  
ENSRNOG00000023162 0.53 QLEKLQETLSSTEEDPSEPLVQNYRVPQPLNQRTIFASFIQVG-PLYTTGEMLGLGMGIS  
ENSCPOG00000006079 0.47 QLERLQQTLFSTEEEPSEALVQNYRAPQPLNQRAVFASFIQVG-PVYTTGEMLSLAVGIV  
ENSDORG00000011692 0.53 QLERLQETLFSTEEESSEPLVQNYRAPQPLNQRTVFASFTQVE-SLYTTGEMVGLGVGIL  
ENSLAFG00000004703 0.51 QLEKLQETLFSTEEEPSELLVQNYRAPQPLNQRSVFASFIQVG-SIYTTGEMLGLGVGIL  
ENSPCAG00000007282 0.49 QLEKLQETLSSTEEEPSKPLVQNYRAPQPLNQRIVFASFIQVA-SVYTTGEMLGLGVGIL  
ENSPVAG00000013464 0.42 QLEKLQETLFSSETDPSELLVQNYRAPQPLNQRPVFASFIQAE-SLYTTGEMLSLGVGIL  
                   cons QLEkLQeTLfStEeepSelLvQNYRapQPLNQRmvFASFiQ g slyttgEmlsLgvGIl  
 
ENSG00000118298    0.59 VGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA  
ENSGGOG00000017116 0.59 VGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA  
ENSPTRG00000001249 0.57 VGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA  
ENSNLEG00000009787 0.63 VGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA  
ENSMMUG00000021385 0.62 VGCLCLLLAVYFIARKIRKKRLENRKTVVFTSARATTEA  
ENSCJAG00000009756 0.60 VGCLCLLLAAYFIARKIRKKRLENRKSVVFTSARATTEA  
ENSOGAG00000004842 0.53 AGCLCLLLAAYFIARKIRKKRLENRKSVVFTSARATTEA  
ENSSTOG00000027815 0.57 IGCLCLLLAVYFIVRKIRKKRLGNRKSVVFTSAQATTEA  
ENSMUSG00000038526 0.55 AGCLCLLLAVYFIAQKIRKKRLGNRKSVVFTSARATTEA  
ENSRNOG00000023162 0.53 AGCLCLLLTIYFIAQKIRRKRLGNRKSVVFTSARATTEA  
ENSCPOG00000006079 0.47 LGCLCLLVAAYFIAKRIRKKRLGNGKSVVFTSVRATTEA  
ENSDORG00000011692 0.53 VGCLCLLLAVYFIAQKIRKKRLGNRKSVVFTSARAAAEA  
ENSLAFG00000004703 0.51 AGCLCLLLAVYFIVRKIRKKRLRNQKSVVFTSAQATTEA  
ENSPCAG00000007282 0.49 AGCLCLLLVVYFIARKIRKKRLRNQKSV-----------  
ENSPVAG00000013464 0.42 VGCLCLLLGVYFIARKIRKKMLGNQKSVVFTSSQATEA-  
                   cons vGCLCLLlavYFIarkIRkKrLeNrKsVvftsa attea  
 
The consensus ('cons') is calculated as follows: the most frequent character in each column is shown in lowercase (unless it is a gap 
character); uppercase letters represent a column containing just one amino acid and no gaps. 
Positively and negatively influencing subsequences are coloured according to the following scale: 
(non-nuclear) negative ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| positive (nuclear) 
 
 
[Note: See Appendix IX for full result files]  
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Appendix V – Ramachandran plot of the comparative model of zebrafish CA VI domain 
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Appendix VI – Ramachandran plot of the comparative model of zebrafish Pentraxin 
domain 
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Appendix VII – Pseudocontact parameters in docked CA VI (3FE4) and AP-helix 
 
The table showing the 45 hydrophobic (pseudo) contact parameters calculated between the selected 
residues of 3FE4 and AP-helix structures after they were docked: 
atom1 atom2 overlap distance 
ALA 234.A CB PHE 289.A CE2 0.355 3.285 
ILE 131.A CB LEU 300.A CD2 0.297 3.463 
PHE 236.A CD1 ILE 296.A CG1 0.284 3.356 
VAL 168.A O LEU 303.A CD1 0.236 3.124 
ALA 234.A O PHE 289.A CE2 0.206 3.034 
ALA 234.A C PHE 289.A CE2 0.19 3.27 
PHE 236.A CE1 LEU 293.A CD1 0.176 3.464 
PHE 236.A CE1 ILE 296.A CG1 0.149 3.491 
ILE 131.A CB LEU 300.A CB 0.106 3.654 
PHE 236.A CE1 ILE 296.A CB 0.076 3.564 
ILE 131.A CG2 LEU 300.A O 0.067 3.293 
VAL 168.A C LEU 303.A CD1 0.066 3.514 
PHE 236.A CZ LEU 293.A CD1 0.062 3.578 
ILE 131.A CG2 LEU 300.A CB 0.024 3.736 
ILE 131.A O LEU 300.A CD2 0.023 3.337 
PHE 236.A CE1 ILE 296.A CG2 0.018 3.622 
VAL 168.A HN LEU 303.A CD2 -0.002 2.882 
ALA 234.A O LEU 293.A CD1 -0.015 3.375 
PHE 236.A CZ ILE 296.A CG2 -0.03 3.67 
PHE 236.A CD1 ILE 296.A CG2 -0.048 3.688 
ILE 131.A CB LEU 300.A CG -0.063 3.823 
VAL 168.A CG2 LEU 303.A CD2 -0.088 3.848 
ALA 234.A CB PHE 289.A CD2 -0.103 3.743 
VAL 134.A CG2 LEU 303.A CD2 -0.109 3.869 
ILE 121.A CD1 LEU 300.A O -0.128 3.488 
ILE 121.A CD1 LEU 303.A OXT -0.134 3.494 
PHE 236.A CE2 ILE 296.A CG2 -0.136 3.776 
ILE 131.A C LEU 300.A CD2 -0.149 3.729 
PHE 236.A CD1 ILE 296.A CB -0.188 3.828 
PHE 236.A CD2 ILE 296.A CG2 -0.198 3.838 
ILE 131.A CG2 LEU 300.A C -0.2 3.78 
ALA 234.A O PHE 289.A CZ -0.213 3.453 
PHE 236.A CG ILE 296.A CG2 -0.223 3.803 
ILE 131.A CG2 LEU 300.A CG -0.225 3.985 
ALA 234.A CA PHE 289.A CE2 -0.237 3.877 
ALA 234.A C PHE 289.A CZ -0.277 3.737 
VAL 168.A N LEU 303.A CD2 -0.312 3.817 
ILE 121.A CD1 LEU 303.A CB -0.313 4.073 
PHE 236.A CE1 LEU 293.A CG -0.319 3.959 
ALA 234.A CA LEU 293.A CD1 -0.322 4.082 
ILE 131.A CA LEU 300.A CD2 -0.324 4.084 
PHE 236.A CZ ILE 296.A CB -0.326 3.966 
PHE 236.A CZ LEU 293.A CG -0.333 3.973 
ILE 131.A CG1 LEU 300.A CB -0.34 4.1 
ILE 131.A CG2 LEU 300.A CD2 -0.395 4.155 
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Appendix VIII – Pseudo contact parameters between docked CA VI and Pentraxin 
 
The table showing 155 pseudo contacts parameters calculated between CA VI and Pentraxin domain of 
the docked model of zebrafish CA VI + Pentraxin protein: 
atom1 atom2 overlap distance 
LEU307.AO LYS 325.B HZ1 0.795 1.685 
LYS300.AHZ1 GLN 326.B OE1 0.7 1.78 
GLU170.AOE1 SER 513.B HG 0.691 1.789 
GLU170.AOE1 LEU 514.B HN 0.651 1.829 
GLU293.AOE2 GLY 522.B HN 0.626 1.854 
CYS290.ACA GLN 521.B HE22 0.508 2.372 
SER304.ACB GLN 326.B CB 0.427 3.333 
GLU294.ACA LEU 520.B O 0.418 2.942 
ASP310.AO LYS 325.B HZ3 0.398 2.082 
ALA297.ACB LEU 331.B CD2 0.394 3.366 
LEU307.AO LYS 325.B NZ 0.391 2.714 
GLY172.ACA SER 513.B OG 0.354 3.026 
GLU170.AOE1 LEU 514.B N 0.342 2.763 
LYS300.ANZ GLN 326.B OE1 0.341 2.764 
GLU293.AOE2 GLY 522.B N 0.34 2.765 
ALA297.ACB LEU 331.B CD1 0.324 3.436 
ASP310.AO LYS 325.B NZ 0.295 2.81 
GLU293.ACB GLN 521.B NE2 0.289 3.216 
CYS290.ACA GLN 521.B NE2 0.284 3.221 
ALA297.ACA LEU 331.B CD1 0.271 3.489 
GLU293.ACB GLN 521.B HE21 0.264 2.616 
GLU170.AOE1 SER 513.B OG 0.248 2.732 
ALA297.ACB LEU 520.B CB 0.236 3.524 
LYS298.ACG LEU 514.B CD2 0.221 3.539 
GLU294.ACG GLN 519.B CB 0.202 3.558 
LEU305.ACD1 LEU 512.B O 0.193 3.167 
CYS290.ACA GLN 521.B OE1 0.172 3.188 
LEU305.ACD2 SER 513.B CA 0.138 3.622 
ARG301.ANE LEU 512.B CB 0.129 3.376 
SER308.ACA GLN 511.B OE1 0.124 3.236 
SER304.ACB GLN 326.B HN 0.106 2.774 
GLU293.AOE1 GLN 521.B HE21 0.105 2.375 
LEU305.ACD1 LEU 512.B C 0.1 3.48 
HIS173.AO LEU 462.B CD2 0.099 3.261 
ARG301.ANH2 THR 510.B CG2 0.095 3.41 
ARG301.ACZ ILE 328.B CD1 0.078 3.502 
ARG301.ANH2 ILE 328.B CG2 0.056 3.449 
GLY172.ACA SER 513.B CB 0.047 3.713 
ARG301.AHH21 THR 510.B CG2 0.045 2.835 
LYS298.ACA LEU 520.B CD1 0.042 3.718 
GLU294.ACB LEU 520.B O 0.04 3.32 
LEU307.AO LYS 325.B CD 0.038 3.322 
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GLU294.ACD GLN 519.B CB 0.022 3.558 
CYS290.ACB GLN 521.B OE1 0.009 3.351 
GLU294.ACG LEU 520.B HN 0.004 2.876 
SER308.AOG GLN 511.B CG 0.003 3.377 
LEU307.ACD1 LYS 325.B CB 0.003 3.757 
SER304.ACB GLN 326.B N -0.011 3.516 
GLU293.ACD GLN 521.B HE21 -0.018 2.718 
ARG301.AHH21 ILE 328.B CG2 -0.019 2.899 
CYS290.ACA GLN 521.B CD -0.02 3.6 
THR240.ACB TYR 515.B CD1 -0.049 3.689 
THR240.ACG2 TYR 515.B CB -0.053 3.813 
SER304.ACA GLN 326.B CB -0.054 3.814 
GLU293.ACD GLN 521.B CG -0.065 3.645 
LYS300.ACD GLN 326.B HE22 -0.066 2.946 
SER308.AOG GLN 511.B CB -0.068 3.448 
ALA297.ACB LEU 331.B CG -0.07 3.83 
LYS300.ACB LEU 331.B CD1 -0.071 3.831 
ARG301.AHE LEU 512.B CB -0.072 2.952 
ARG301.ANH1 ILE 328.B CG2 -0.08 3.585 
THR240.ACG2 TYR 515.B CD1 -0.082 3.722 
GLU293.AOE2 GLY 522.B CA -0.088 3.448 
LYS298.ACE VAL 518.B O -0.09 3.45 
LYS300.ACG GLN 326.B NE2 -0.095 3.6 
HIS173.ANE2 ASN 347.B CG -0.098 3.423 
LYS300.AHZ1 GLN 326.B CD -0.1 2.8 
LYS300.ACD LEU 331.B CD1 -0.102 3.862 
PHE174.ACZ TYR 515.B CZ -0.107 3.567 
LYS298.ACE LEU 514.B CD2 -0.112 3.872 
ARG301.AHE LEU 512.B CD1 -0.112 2.992 
SER308.ACB GLN 511.B CG -0.113 3.873 
GLU293.AOE2 GLN 521.B CG -0.116 3.476 
PHE174.ACE2 TYR 515.B CE1 -0.118 3.638 
ARG301.AHE LEU 512.B CG -0.129 3.009 
GLU170.ACD SER 513.B HG -0.131 2.831 
ARG301.ACG ILE 328.B CD1 -0.132 3.892 
ARG301.ANH1 ILE 328.B CD1 -0.136 3.641 
LEU307.AO LYS 325.B CE -0.143 3.503 
SER308.ACB GLN 511.B CD -0.146 3.726 
ARG301.ACG LEU 520.B CD2 -0.148 3.908 
LEU307.AC LYS 325.B HZ1 -0.157 2.857 
MET289.AO GLN 521.B HE22 -0.164 2.644 
HIS173.AHE2 ASN 347.B CG -0.176 2.876 
HIS173.AHE2 ASN 347.B ND2 -0.178 2.803 
ARG301.AHH11 ILE 328.B CG2 -0.182 3.062 
SER308.ACB GLN 511.B OE1 -0.182 3.542 
HIS173.ANE2 ASN 347.B OD1 -0.185 3.29 
HIS173.ACE1 ARG 451.B NE -0.185 3.57 
LEU305.ACD1 SER 513.B CA -0.186 3.946 
SER304.ACB GLN 326.B CA -0.187 3.947 
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LEU305.ACD2 LEU 512.B O -0.187 3.547 
GLU170.AOE1 SER 513.B CA -0.19 3.55 
GLU293.ACD GLY 522.B HN -0.191 2.891 
CYS290.AO GLN 521.B NE2 -0.192 3.297 
LYS300.ACD GLN 326.B NE2 -0.192 3.697 
GLU170.ACD LEU 514.B HN -0.196 2.896 
SER304.ACB LYS 325.B N -0.198 3.718 
ARG301.ANH1 ILE 328.B CB -0.199 3.704 
LEU307.ACB LYS 325.B CD -0.202 3.962 
ARG301.ACD LEU 512.B CB -0.205 3.965 
ARG301.ACZ ILE 328.B CG2 -0.218 3.798 
GLU293.AOE1 GLN 521.B NE2 -0.238 3.343 
THR240.AOG1 TYR 515.B CD1 -0.249 3.509 
LYS300.ACG GLN 326.B CD -0.257 3.837 
ASP310.AO LYS 325.B HZ1 -0.259 2.739 
CYS290.AO GLN 521.B CD -0.261 3.441 
ARG301.ANE ILE 328.B CD1 -0.27 3.775 
LYS298.ACG LEU 520.B CD1 -0.27 4.03 
LYS300.ACG LEU 331.B CD1 -0.273 4.033 
ALA297.AO LEU 331.B CD1 -0.273 3.633 
PHE174.ACZ TYR 515.B OH -0.276 3.536 
ARG301.ANE LEU 512.B CG -0.281 3.786 
ARG301.ANE LEU 512.B CD1 -0.287 3.792 
GLU294.ACG LEU 520.B O -0.292 3.652 
MET289.AO GLN 521.B NE2 -0.292 3.397 
GLU294.ACG GLN 519.B CA -0.294 4.054 
LYS300.ACG GLN 326.B HE22 -0.299 3.179 
LYS300.ACG GLN 326.B OE1 -0.301 3.661 
SER308.ACA GLN 511.B CD -0.312 3.892 
GLU293.ACG GLN 521.B HE21 -0.313 3.193 
LEU305.ACD1 SER 513.B N -0.314 3.819 
SER304.AO LYS 325.B HN -0.315 2.795 
GLU170.AOE1 SER 513.B CB -0.315 3.675 
ARG301.ANH2 ILE 328.B CD1 -0.315 3.82 
GLU294.ACG LEU 520.B N -0.316 3.821 
GLU293.ACD GLN 521.B NE2 -0.321 3.646 
CYS290.AO GLN 521.B OE1 -0.323 3.283 
PHE174.ACE1 TYR 515.B CE2 -0.326 3.846 
PHE174.ACZ TYR 515.B CE1 -0.329 3.849 
GLU170.AOE1 LEU 514.B CA -0.34 3.7 
HIS173.ANE2 ASN 347.B ND2 -0.341 3.591 
GLU294.ACB GLN 519.B NE2 -0.348 3.853 
LYS300.ACD GLN 326.B OE1 -0.349 3.709 
HIS173.AHE2 ASN 347.B OD1 -0.35 2.83 
HIS173.ACE1 ARG 451.B CZ -0.35 3.81 
ARG301.ACD LEU 512.B CD1 -0.358 4.118 
LEU307.ACD1 LYS 325.B CA -0.361 4.121 
CYS290.AC GLN 521.B HE22 -0.362 3.062 
CYS290.AN GLN 521.B HE22 -0.368 2.993 
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PHE174.ACE1 TYR 515.B CZ -0.368 3.828 
SER308.ACB GLN 511.B CB -0.373 4.133 
HIS173.ACE1 ARG 451.B NH2 -0.373 3.758 
CYS290.AC GLN 521.B NE2 -0.374 3.699 
ALA297.ACB LEU 520.B C -0.375 3.955 
PHE174.ACD2 TYR 515.B CE1 -0.375 3.895 
LEU307.ACB LYS 325.B CB -0.375 4.135 
LEU305.ACD1 LEU 512.B N -0.381 3.886 
HIS173.ACD2 ASN 347.B CG -0.383 3.843 
MET289.AC GLN 521.B HE22 -0.386 3.086 
ALA297.ACB GLN 521.B N -0.387 3.892 
LYS298.ACB LEU 520.B CD1 -0.393 4.153 
GLU170.AOE1 SER 513.B C -0.393 3.573 
ARG301.ACZ LEU 512.B CB -0.394 3.974 
GLY172.ACA SER 513.B HG -0.398 3.278 
 
  
 83 
 
Appendix IX – Dropbox links of supplementary files 
 
NetNES output of CA IX orthologues: 
https://www.dropbox.com/s/fxek2orwyfdgumf/NetNES_output_CAIX.pdf?dl=0  
NetNES output of CA XII orthologues: 
https://www.dropbox.com/s/0yzloz02qg1ryza/NetNES_output_CAXII.pdf?dl=0  
NetNES output of CA XIV orthologues: 
https://www.dropbox.com/s/d42340wa0s5fbhy/NetNES_output_CAXIV.pdf?dl=0  
NucPred output of CA IX orthologues: 
https://www.dropbox.com/s/2dyscw9n94nxksf/NucPred_output_CAIX.pdf?dl=0  
NucPred output of CA XII orthologues: 
https://www.dropbox.com/s/rwi979w5pvmtez7/NucPred_output_CAXII.pdf?dl=0  
NucPred output of CA XIV orthologues: 
https://www.dropbox.com/s/hm5mnnzfksvxhwm/NucPred_output_CAXIV.pdf?dl=0  
Pdb file of docked model of zebrafish CA VI and Pentraxin domains: 
https://www.dropbox.com/s/trykeo5ch0u0zep/Danio_CAviPtx.pdb?dl=0  
